The present invention generally relates to medical devices and methods, and more particularly relates to devices and methods for loading a prosthesis onto a delivery system. The prosthesis may be any device but in preferred embodiments is used to treat valve insufficiency, such as mitral insufficiency, also referred to as mitral regurgitation. The delivery system may be any system used to deliver the prosthesis either by traditional surgical implantation methods, or by less invasive percutaneous catheter or minimally invasive transapical methods.
The heart of vertebrate animals is divided into four chambers, and is equipped with four valves (the mitral, aortic, pulmonary and tricuspid valves) that ensure that blood pumped by the heart flows in a forward direction through the cardiovascular system. The mitral valve of a healthy heart prevents the backflow of blood from the left ventricle into the left atrium of the heart, and comprises two flexible leaflets (anterior and posterior) that close when the left ventricle contracts. The leaflets are attached to a fibrous annulus, and their free edges are tethered by subvalvular chordae tendineae to papillary muscles in the left ventricle to prevent them from prolapsing into the left atrium during the contraction of the left ventricle.
Various cardiac diseases or degenerative changes may cause dysfunction in any of these portions of the mitral valve apparatus, causing the mitral valve to become abnormally narrowed or dilated, or to allow blood to leak (also referred to as regurgitate) from the left ventricle back into the left atrium. Any such impairments compromise cardiac sufficiency, and can be debilitating or life threatening.
Numerous surgical methods and devices have accordingly been developed to treat mitral valve dysfunction, including open-heart surgical techniques for replacing, repairing or re-shaping the native mitral valve apparatus, and the surgical implantation of various prosthetic devices such as annuloplasty rings to modify the anatomy of the native mitral valve. More recently, less invasive transcatheter techniques for the delivery of replacement mitral valve assemblies have been developed. In such techniques, a prosthetic valve is generally mounted in a crimped state on the end of a flexible catheter and advanced through a blood vessel or the body of the patient until the valve reaches the implantation site. The prosthetic valve is then expanded to its functional size at the site of the defective native valve.
While these devices and methods are promising treatments for valvar insufficiency, they can be difficult to deliver, and difficult to load onto the delivery system. Therefore, it would be desirable to provide improved devices and methods for coupling the prosthesis with the delivery system. At least some of these objectives will be met by the devices and methods disclosed below.
By way of example, PCT international patent number PCT/US2008/0544 0 (published as PCT international publication no. WO2008/103722), the disclosure of which is hereby incorporated by reference, describes a transcatheter mitral valve prosthesis that comprises a resilient ring, a plurality of leaflet membranes mounted with respect to the ring so as to permit blood flow therethrough in one direction, and a plurality of tissue-engaging positioning elements movably mounted with respect to the ring and dimensioned to grip the anatomical structure of the heart valve annulus, heart valve leaflets, and/or heart wall. Each of the positioning elements defines respective proximal, intermediate, and distal tissue engaging regions cooperatively configured and dimensioned to simultaneously engage separate corresponding areas of the tissue of an anatomical structure, and may include respective first, second, and third elongate tissue-piercing elements. The valve prosthesis may also include a skirt mounted with respect to the resilient ring for sealing a periphery of the valve prosthesis against a reverse flow of blood around the valve prosthesis.
PCT international patent number PCT/US2009/041754 (published as PCT international publication no. WO2009/134701), the disclosure of which is hereby incorporated by reference, describes a prosthetic mitral valve assembly that comprises an anchor or outer support frame with a flared upper end and a tapered portion to fit the contours of the native mitral valve, and a tissue-based one-way valve mounted therein. The assembly is adapted to expand radially outwardly and into contact with the native heart tissue to create a pressure fit, and further includes tension members anchoring the leaflets of the valve assembly to a suitable location on the heart to function as prosthetic chordae tendineae.
Also known are prosthetic mitral valve assemblies that utilize a claw structure for attachment of the prosthesis to the heart (see, for example, U.S. patent application publication no. US2007/0016286 to Hermann et al., the disclosure of which is hereby incorporated by reference), as are prosthetic mitral valve assemblies that rely on the application of axial rather than radial clamping forces to facilitate the self-positioning and self-anchoring of the prosthesis with respect to the native anatomical structure.
Another method which has been proposed as a treatment of mitral valve regurgitation is the surgical bow tie method, which recently has been adapted into a minimally invasive catheter based treatment where an implant is used to clip the valve leaflets together. This procedure is more fully disclosed in the scientific and patent literature, such as in U.S. Pat. No. 6,629,534 to St. Goar et al., the entire contents of which are incorporated herein by reference.
Other relevant publications include U.S. Patent Publication No. 2011/0015731 to Carpentier et al. and WO 2011137531 to Lane et al. While some of these devices and methods are promising, there still is a need for improved devices and methods that will further allow more accurate positioning of a prosthetic valve and that will also more securely anchor the valve in place. In addition to needing improved devices, there is also a need for improved delivery systems and improved tools or devices and methods for loading the devices onto their respective delivery systems. At least some of these objectives will be met by the exemplary embodiments disclosed herein.
The present invention generally relates to medical devices and methods, and more particularly relates to devices and methods for loading a prosthesis onto a delivery system. The prosthesis may be any device but in preferred embodiments is used to treat valve insufficiency, such as mitral insufficiency, also referred to as mitral regurgitation. The delivery system may be any system used to deliver the prosthesis either by traditional surgical implantation methods, or by less invasive percutaneous catheter or minimally invasive transapical methods. While the present disclosure focuses on fixtures for loading the prosthesis onto a delivery system, this is not intended to be limiting. The prosthetic valves disclosed herein may also be used to treat other body valves including other heart valves or venous valves. Exemplary heart valves include the aortic valve, the triscupsid valve, or the pulmonary valve. The loading devices disclosed herein may be used to load any prosthesis onto any delivery system.
In a first aspect of the present invention, a device for loading a prosthesis onto a delivery system comprises a first housing comprising a first inlet, a first outlet, and a first central bore extending therebetween. The first housing has one or more actuators configured to actuate radially inward or outward, and the one or more actuators are adapted to selectively compress a discrete portion of the prosthesis radially inward when the prosthesis is disposed in the first central bore and while adjacent portions of the prosthesis remain uncompressed by the one or more actuators.
The first central bore may comprise a constant diameter region or a first tapered region adapted to radially collapse the prosthesis from a first initial diameter to a smaller diameter when the prosthesis is passed therethrough. The one or more actuators may comprise three actuators circumferentially disposed around the first housing about every 120 degrees. The one or more actuators may be operably coupled together such that they are actuated simultaneously. The device may further comprise a collar that is threadably engaged with the first housing. Rotating the collar actuates the one or more actuators. The one or more actuators may comprise spring loaded actuators biased to return to a position disposed radially outward from the first central bore. The first housing may further comprise a plurality of engagement elements for engaging an adjacent housing. The device may also include a support element that is releasably engaged with the first housing. The inner support element may be configured to support an inner surface of the prosthesis.
The device may further comprise a second housing coupleable end-to-end with the first housing. The second housing may comprise a second inlet, a second outlet, and a second central bore extending therebetween. The second central bore may have a second tapered region that is adapted to radially collapse the prosthesis from a second initial diameter to a second smaller diameter as the prosthesis is advanced through the second central bore. The second central bore may further comprise a second constant diameter region in communication with the first central bore and proximal thereof. The second central bore may further comprise a filleted region disposed between the second tapered region and the second constant diameter region. The second central bore may be at least partially cylindrically shaped. The second housing may comprise a plurality of engagement elements for releasably engaging the second housing with an adjacent housing, or a plurality of engagement receptacles for receiving engagement elements on an adjacent housing. The plurality of engagement elements may comprise three engagement tabs arranged circumferentially around the first housing approximately every 120 degrees. Passage of the prosthesis through the second central bore may shape the prosthesis to have a circular cross-section.
The device may further comprise a third housing coupleable end-to-end with the first or the second housing. The third housing may comprise a third inlet, a third outlet, and a third central bore extending therebetween and in communication with the first central bore or the second central bore. The third central bore may have a third tapered region adapted to radially collapse the prosthesis from a third diameter to a diameter smaller than the third diameter as the prosthesis is advanced through the third central bore. The third central bore may further comprise a third constant diameter region in communication with the third tapered region and distal thereto. The third central bore may also comprise a filleted region disposed between the third tapered region and the third constant diameter region. The third central bore may be at least partially cylindrically shaped. The third housing may comprise a plurality of engagement elements for releasably engaging an adjacent housing. The third housing may comprise a plurality of engagement receptacles for receiving engagement elements on an adjacent housing. The plurality of engagement elements may comprise three engagement tabs arranged circumferentially around the first housing approximately every 120 degrees. Passage of the prosthesis through the third central bore may shape the prosthesis to have a circular cross-section.
The prosthesis may comprise a prosthetic heart valve, and may comprise a plurality of anchoring tabs, and wherein actuation of the one or more actuators is adapted to move the plurality of anchoring tabs radially inward. The plurality of anchoring tabs may be adapted to be releasably engaged with retaining features on the delivery catheter. The plurality of anchoring tabs may comprise commissure posts on a prosthetic heart valve.
In another aspect of the present invention, a system for loading a prosthesis onto a delivery system comprises the loading device described above in addition to a prosthetic heart valve and a delivery device.
In still another aspect of the present invention, a method for loading a prosthesis onto a delivery system comprises providing a prosthetic valve having a plurality of commissure posts coupled thereto, wherein the prosthetic valve comprises an unbiased diameter, and reducing the unbiased diameter of the prosthetic valve in selected discrete regions, the selected discrete regions comprising the commissure posts. The method also includes loading the reduced diameter prosthetic valve onto a delivery device.
Reducing the unbiased diameter of the prosthetic valve may comprise actuating one or more actuators on a first housing, wherein the one or more actuators may selectively engage discrete regions of the prosthetic valve. The method may further comprise passing the prosthetic valve through a constant diameter portion of a central channel in the first housing. Actuating the one or more actuators may comprise depressing one or more pins or fingers radially inward to engage the discrete regions of the prosthetic valve. The discrete regions may move radially inward into a reduced profile. Depressing may comprise simultaneously depressing the one or more pins or fingers.
The method may further comprise reducing diameter of the prosthetic valve from the unbiased diameter to a first diameter less than the unbiased diameter. Reducing diameter of the prosthetic valve from the unbiased diameter to the first diameter may comprise passing the prosthetic valve through a tapered central channel Passing the prosthetic valve through the tapered central channel may comprise pushing or pulling the prosthetic valve therethrough. Passing the prosthetic valve through the tapered central channel may comprise shaping the prosthetic valve to have a circular cross-section.
The method may further comprise reducing diameter of the prosthetic valve from the first diameter to a second diameter less than the first diameter. Reducing diameter from the first diameter to the second diameter may comprise passing the prosthetic valve through a second tapered central channel Passing the prosthetic valve through the second tapered central channel may comprise pushing or pulling the prosthetic valve therethrough.
The delivery device may comprise an inner shaft and an outer shaft slidably disposed thereover, and loading the reduced diameter prosthetic valve may comprise disposing the prosthetic valve between the inner shaft and outer shafts. Loading the reduced diameter prosthetic valve may comprise releasably engaging the commissure posts with the delivery device.
The prosthetic valve may be fabricated from a nickel titanium alloy, and the method may further comprise cooling the prosthetic valve to a temperature less than or equal to the austenitic finish temperature of the prosthetic valve. Cooling the prosthetic valve may comprise cooling the prosthetic valve in chilled saline. The diameter of the prosthetic valve may be reduced from the unbiased diameter to the first diameter in a first housing, and the diameter of the prosthetic valve may be reduced from the first diameter to the second diameter in a second housing, and the method may further comprise coupling the first housing with the second housing. The first housing and the second housing may be uncoupled from one another after the diameter has been reduced to the first diameter. The method may also comprise supporting an inner surface of the prosthesis with a support element.
These and other embodiments are described in further detail in the following description related to the appended drawing figures.
All publications, patents, and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference.
The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
Specific embodiments of the disclosed device, delivery system, and method will now be described with reference to the drawings. Nothing in this detailed description is intended to imply that any particular component, feature, or step is essential to the invention.
Cardiac Anatomy.
The left ventricle LV of a normal heart H in systole is illustrated in
Referring now to
Regurgitation also occurs in the patients suffering from cardiomyopathy where the heart is dilated and the increased size prevents the valve leaflets LF from meeting properly, as shown in
Mitral valve regurgitation can also occur in patients who have suffered ischemic heart disease where the functioning of the papillary muscles PM is impaired, as illustrated in
While various surgical techniques as well as implantable devices have been proposed and appear to be promising treatments for mitral regurgitation, surgical approaches can require a lengthy recovery period, and implantable devices have varying clinical results. Therefore, there still is a need for improved devices, delivery systems, loading fixtures, and methods for treating mitral regurgitation. While the embodiments disclosed herein are directed to an implantable prosthetic mitral valve for treating mitral regurgitation, one of skill in the art will appreciate that this is not intended to be limiting, and the devices and methods disclosed herein may also be used to treat other cardiac valves such as the tricuspid valve, aortic valve, pulmonary valve, etc, as well as other valves in the body such as venous valves.
Prosthetic Valve.
Prosthetic valves have been surgically implanted in the heart as a treatment for mitral regurgitation. Some of these valves have been valves harvested from animals such as porcine valves, and others have been prosthetic mechanical valves with or without a tissue covering. More recently, minimally invasive catheter technology has been used to deliver prosthetic valves to the heart. These valves typically include an anchor for securing the valve to the patient's heart, and a valve mechanism, either a mechanical valve, a valve with animal tissue, or combinations thereof. The prosthetic valve once implanted, takes over for malfunctioning native valve, thereby reducing or eliminating valvar insufficiency. While some of these valves appear promising, there still is a need for improved valves. Positioning and anchoring the prosthetic valve in the native anatomy remains a challenge. The following discloses exemplary embodiments of a prosthetic valve, a delivery system for the prosthetic valve, and methods of delivering the valve that overcome some of the challenges associated with existing prosthetic valves.
Atrial region 606 has a skirt 616 which includes a plurality of interconnected struts that form a series of peaks and valleys. In this region, the struts are skew relative to one another and thus the resulting cell pattern has an enlarged end and the opposite end tapers to a smaller end. In preferred embodiments, the anterior portion of the atrial skirt does not have a flanged region like the posterior portion, thus the anterior portion 602 of the atrial region may have shorter struts than the posterior region 604. Thus the peaks and valleys in the anterior portion are axially offset from those in the remaining posterior portion of the atrial region. This may be advantageous as it prevents the struts in the anterior portion of the atrial skirt from protruding upwards potentially impinging against the left atrium and causing perforations. Additionally, the shortened struts and offset peaks and valleys form an alignment element 614 that can assist the physician visualize delivery of the prosthetic valve to the mitral valve and alignment of the prosthetic valve prior to expansion of the prosthetic valve. Optional radiopaque markers 614a are disposed on either side of the offset peaks and valleys and further help with visualization during implantation of the valve. The atrial region preferably self-expands to either a cylindrical shape, or it may have a D-shaped cross-section where the anterior portion 602 is substantially flat, and the posterior portion 604 is cylindrically shaped. This allows the atrial skirt to conform to the anatomy of the native mitral valve, thereby preventing obstruction of the left ventricular outflow tract. Additionally, the atrial skirt may also be formed so that upon expansion, the skirt flares outward and forms a flange that can rest against a superior surface of the mitral valve. The flanged region is preferably along the posterior portion of the atrial skirt, and the anterior portion of the atrial skirt remains flangeless. Or, the flange may extend entirely around the atrial skirt. The atrial region is connected to the adjacent annular region 608 with connecting struts which are preferably linear and substantially parallel to the longitudinal axis of the frame.
The annular region 608 is also comprised of a plurality of axially oriented and interconnected struts that form peaks and valleys that allow radial expansion. The struts are preferably parallel with one another and parallel with the longitudinal axis of the frame. The annular region may also be self-expanding and expand into a cylindrical shape, or more preferably the annular region may expand to have a D-shaped cross-section as described above with respect to the atrial region. Thus, the annular region may similarly have a flat anterior portion, and a cylindrically shaped posterior portion. Upon delivery, the annular region is aligned with and expanded into engagement with the mitral valve annulus. Connector struts join the annular region with the ventricular region 610.
The ventricular region 610 also includes a plurality of interconnected struts that form peaks and valleys. Additionally, the struts in the ventricular region form the leaflet commissures 613 which are covered with fabric, pericardial tissue, or other materials to form the prosthetic valve leaflets. Holes in the commissures allow suture to be attached thereto. Struts in the ventricular region also form a ventricular skirt 628 which expands outward to engage the anterior and posterior mitral valve leaflets, and struts in the ventricular region also form the anterior tabs 624 and the posterior tab 630. The anterior tabs are designed to capture the anterior mitral valve leaflet between an inner surface of the anterior tab and outer surface of the ventricular skirt. Any adjacent chordae tendineae may also be captured therebetween. Also, the tip of the anterior tab engages the fibrous trigone on an anterior portion of the mitral valve, one on the left and one on the right side. The posterior tab similarly captures the posterior mitral valve leaflet between an inner surface of the posterior tab and an outer surface of the ventricular skirt, along with any adjacent chordae tendineae. This will be described in more detail below.
By controlling strut length or axial position of the anterior or posterior tabs along the frame, deployment of the tabs may be controlled. Thus in this exemplary embodiment, because the length of the struts in the anterior tabs and posterior tabs 624, 630 as well as their relative position along the frame are the same as one another, when a constraining sheath is retracted away from the tabs, the anterior and posterior tabs will partially spring outward together. As the constraining sheath is further retracted, the remainder of the anterior tabs will self-expand radially outward. Further retraction of the constraining sheath then allows the remainder of the posterior tab to finish its radial expansion, and finally the ventricular skirt will radially expand outward. While strut lengths and axial position of the posterior tab and the ventricular skirt are similar, internal struts connect the ventricular skirt with the commissures, and this delays expansion of the ventricular skirt slightly, thus the posterior tab finishes expansion before the ventricular skirt. Using this sequence of deploying the prosthetic valve may allow the valve to more accurately delivered and also more securely anchored into position.
Suture holes 621 are disposed along the struts of the annular region as well as the ventricular region to allow attachment of a cover such as pericardium or a polymer such as Dacron or ePTFE. The suture holes may also be disposed along any other part of the frame. Barbs 623 are disposed along the ventricular skirt 628 to help anchor the prosthetic valve to adjacent tissue. Commissure tabs or tabs 612 are disposed on the tips of the commissures 613 and may be used to releasably couple the commissures with a delivery system as will be described below. This allows the frame to expand first, and then the commissures may be released from the delivery system afterwards. One of skill in the art will appreciate that a number of strut geometries may be used, and additionally that strut dimensions such as length, width, thickness, etc. may be adjusted in order to provide the anchor with the desired mechanical properties such as stiffness, radial crush strength, commissure deflection, etc. Therefore, the illustrated geometry is not intended to be limiting.
The frame may be formed by EDM, laser cutting, photochemical etching, or other techniques known in the art. Hypodermic tubing or flat sheets may be used to form the frame. Once the frame has been cut and formed into a cylinder, it may be radially expanded into a desired geometry and heat treated using known processes to set the shape. Thus, the prosthetic valve may be loaded onto a delivery catheter in a collapsed configuration and constrained in the collapsed configuration with a constraining sheath. Removal of the constraining sheath will allow the anchor to self-expand into its unbiased pre-set shape. In other embodiments, an expandable member such as a balloon may be used to radially expand the anchor into its preferred expanded configuration.
Atrial region 706 has a skirt 716 which includes a plurality of interconnected struts that form a series of peaks and valleys. In this region, the struts are skew relative to one another and thus the resulting cell pattern has an enlarged end and the opposite end tapers to a smaller end. An anterior portion 702 of the atrial region has shorter struts than the posterior region 704. Thus the peaks and valleys in the anterior portion are axially offset from those in the remaining posterior portion of the atrial region. This allows creation of an alignment element 714 to help the physician deliver the prosthetic valve to the mitral valve and align the prosthetic valve prior to expansion of the prosthetic valve. Other aspects of the atrial region 706 are similar to those of the atrial region 606 in
The annular region 708 is also comprised of a plurality of axially oriented and interconnected struts that form peaks and valleys that allow radial expansion. The struts are preferably parallel with one another and parallel with the longitudinal axis of the frame. The annular region may also be self-expanding and expand into a cylindrical shape, or more preferably the annular region may expand to have a D-shaped cross-section as described above with respect to the atrial region. Thus, the annular region may similarly have a flat anterior portion, and a cylindrically shaped posterior portion. Upon delivery, the annular region is aligned with and expanded into engagement with the mitral valve annulus. Connector struts join the annular region with the ventricular region 710.
The ventricular region 710 also includes a plurality of interconnected struts that form peaks and valleys. Additionally, the struts in the ventricular region form the leaflet commissures 713 which are covered with fabric, pericardial tissue, or other materials to form the prosthetic valve leaflets. Holes in the commissures allow suture to be attached thereto. Struts in the ventricular region also form a ventricular skirt 728 which expands outward to engage the anterior and posterior mitral valve leaflets, and struts in the ventricular region also form the anterior tabs 724 and the posterior tab 730. The anterior tabs are designed to capture the anterior mitral valve leaflet between an inner surface of the anterior tab and outer surface of the ventricular skirt. Any adjacent chordae tendineae may also be captured therebetween. Also, the tip of the anterior tab engages the fibrous trigone on an anterior portion of the mitral valve, one on the left and one on the right side. The posterior tab similarly captures the posterior mitral valve leaflet between an inner surface of the posterior tab and an outer surface of the ventricular skirt, along with any adjacent chordae tendineae. This will be described in more detail below.
By controlling strut length or axial position of the anterior or posterior tabs along the frame, deployment of the tabs may be controlled. Thus in this exemplary embodiment, because the length of the struts in the anterior tabs and posterior tabs 724, 730 as well as their relative position along the frame are the same as one another, when a constraining sheath is retracted away from the tabs, the anterior and posterior tabs will partially spring outward together. As the constraining sheath is further retracted, the remainder of the anterior tabs will self-expand radially outward because they are the shortest relative to the struts in the ventricular skirt and the posterior tab. Further retraction of the constraining sheath then allows the ventricular skirt to radially expand, and finally further retraction of the sheath allows the remainder of the posterior tab to finish it's radial expansion. Using this sequence of deploying the prosthetic valve may allow the valve to more accurately be delivered and also more securely anchored into position.
Suture holes 721 are disposed along the struts of the annular region as well as the ventricular region to allow attachment of a cover such as pericardium or a polymer such as Dacron or ePTFE. The suture holes may also be disposed along any other part of the frame. Barbs 723 are disposed along the ventricular skirt 728 to help anchor the prosthetic valve to adjacent tissue. Commissure tabs or tabs 712 are disposed on the tips of the commissures 713 and may be used to releasably couple the commissures with a delivery system as will be described below. This allows the frame to expand first, and then the commissures may be released from the delivery system afterwards. One of skill in the art will appreciate that a number of strut geometries may be used, and additionally that strut dimensions such as length, width, thickness, etc. may be adjusted in order to provide the anchor with the desired mechanical properties such as stiffness, radial crush strength, commissure deflection, etc. Therefore, the illustrated geometry is not intended to be limiting. The frame may be formed similarly as described above with respect to
Atrial region 806 has a skirt 816 which includes a plurality of interconnected struts that form a series of peaks and valleys. In this region, the struts are skew relative to one another and thus the resulting cell pattern has an enlarged end and the opposite end tapers to a smaller end. An anterior portion 802 of the atrial region has shorter struts than the posterior region 804. Thus the peaks and valleys in the anterior portion are axially offset from those in the remaining posterior portion of the atrial region. This allows creation of an alignment element 814 to help the physician deliver the prosthetic valve to the mitral valve and align the prosthetic valve prior to expansion of the prosthetic valve. Other aspects of the atrial region 806 are similar to those of the atrial region 606 in
The annular region 808 is also comprised of a plurality of axially oriented and interconnected struts that form peaks and valleys that allow radial expansion. The struts are preferably parallel with one another and parallel with the longitudinal axis of the frame. The annular region may also be self-expanding and expand into a cylindrical shape, or more preferably the annular region may expand to have a D-shaped cross-section as described above with respect to the atrial region. Thus, the annular region may similarly have a flat anterior portion, and a cylindrically shaped posterior portion. Upon delivery, the annular region is aligned with and expanded into engagement with the mitral valve annulus. Connector struts join the annular region with the ventricular region 810.
The ventricular region 810 also includes a plurality of interconnected struts that form peaks and valleys. Additionally, the struts in the ventricular region form the leaflet commissures 813 which are covered with fabric, pericardial tissue, or other materials to form the prosthetic valve leaflets. Holes in the commissures allow suture to be attached thereto. Struts in the ventricular region also form a ventricular skirt 828 which expands outward to engage the anterior and posterior mitral valve leaflets, and struts in the ventricular region also form the anterior tabs 824 and the posterior tab 830. The anterior tabs are designed to capture the anterior mitral valve leaflet between an inner surface of the anterior tab and outer surface of the ventricular skirt. Any adjacent chordae tendineae may also be captured therebetween. Also, the tip of the anterior tab engages the fibrous trigone on an anterior portion of the mitral valve, one on the left and one on the right side. The posterior tab similarly captures the posterior mitral valve leaflet between an inner surface of the posterior tab and an outer surface of the ventricular skirt, along with any adjacent chordae tendineae. This will be described in more detail below. The posterior tab is similar to the posterior tabs described above in
By controlling strut length or axial position of the anterior or posterior tabs along the frame, deployment of the tabs may be controlled. Thus in this exemplary embodiment, because the length of the struts in the anterior tabs and posterior tabs 824, 830 as well as their relative position along the frame are the same as one another, when a constraining sheath is retracted away from the tabs, the anterior and posterior tabs will partially spring outward together. As the constraining sheath is further retracted, the remainder of the anterior tabs will self-expand radially outward because they are the shortest relative to the struts in the ventricular skirt and the posterior tab. Further retraction of the constraining sheath then allows the remainder of the posterior tab to finish self-expanding, followed by self-expansion of the ventricular skirt. Using this sequence of deploying the prosthetic valve may allow the valve to more accurately be delivered and also more securely anchored into position.
Suture holes 821 are disposed along the struts of the annular region as well as the ventricular region to allow attachment of a cover such as pericardium or a polymer such as Dacron or ePTFE. The suture holes may also be disposed along any other part of the frame. Barbs 823 are disposed along the ventricular skirt 828 to help anchor the prosthetic valve to adjacent tissue. Commissure tabs or tabs 812 are disposed on the tips of the commissures 813 and may be used to releasably couple the commissures with a delivery system as will be described below. This allows the frame to expand first, and then the commissures may be released from the delivery system afterwards. One of skill in the art will appreciate that a number of strut geometries may be used, and additionally that strut dimensions such as length, width, thickness, etc. may be adjusted in order to provide the anchor with the desired mechanical properties such as stiffness, radial crush strength, commissure deflection, etc. Therefore, the illustrated geometry is not intended to be limiting. The frame may be formed similarly as described above with respect to those previously described above.
The frame also includes the annular region 910 and ventricular skirt 912. Anterior tabs 904 (only one visible in this view) is fully expanded such that a space exists between the inner surface of the anterior tab and and outer surface of the ventricular skirt. This allows the anterior leaflet and adjacent chordae to be captured therebetween. Similarly, the posterior tab 902 is also fully deployed, with a similar space between the inner surface of the posterior tab 902 and an outer surface of the ventricular skirt. This allows the posterior leaflet and adjacent chordae tendineae to be captured therebetween. The commissure posts 908 are also visible and are disposed in the inner channel formed by the frame. The commissure posts are used to form the prosthetic mitral valve leaflets. The overall shape of the expanded frame is D-shaped, with the anterior portion flat and the posterior portion cylindrically shaped.
Delivery System.
Any of the prosthetic cardiac valves disclosed herein may be carried by delivery system 1100. The atrial skirt, annuar skirt, anterior tabs, posterior tab and ventricular skirt are loaded over the bell catheter shaft and disposed under the outer sheath catheter shaft 1102. The ventricular skirt is loaded proximally so that it is closest to the handle 1112 and the atrial skirt is loaded most distally so it is closest to the tip 1110. Therefore, retraction of outer sheath catheter shaft 1102 plays a significant part in controlling deployment of the prosthetic cardiac valve. The atrial skirt therefore expands first when the outer sheath catheter is retracted. The prosthetic valve commissures may be coupled with a hub 1106a on the distal portion of hub catheter 1106 and then the bell catheter shaft is disposed thereover, thereby releasably engaging the commissures with the delivery catheter. Once other portions of the prosthetic cardiac valve have expanded, the commissures may be released.
Loading Fixture.
The prosthetic valve may be loaded manually by a physician onto the delivery system, but this can be challenging since the valve must be properly oriented relative to the delivery system and then the commissure posts must also be engaged with the slots or receptacles on the delivery system, and captured therein. This may require multiple operators to simultaneously manipulate the prosthesis as well as the delivery system and its actuator mechanisms. Therefore, it would be advantageous to provide a fixture to facilitate loading of the prosthetic valve onto the delivery system.
An internal channel 1439 begins at the first housing 1405 with an inlet orifice 1402 and terminates at the third housing 1409 at an outlet orifice 1403. Three hand operated and spring loaded actuators 1404 are located in the third housing 1409 and are used to depress certain portions of a prosthesis such as a prosthetic heart valve in order to load the valve onto a delivery system, the details of which are described in greater detail below.
As can be seen in
The internal mechanical components of the loading system 1401 are displayed in cross-sectional view in
As seen in
As seen in
One of skill in the art will appreciate that the loading device is not limited to three separate housings. Alternative embodiments of the device may include a single housing that incorporates some or all of the features of the three individual housings. Single housing embodiments are illustrated in
As shown in
As shown in
The final compressed location of a generic prosthetic heart valve 1424 within the C stage 1409 can be seen in
As can be seen in
As seen in
Three locking pegs 2705 on the circumference of the outer cone 2704 allow the base of the outer cone 2704 to be mated to the locking mechanism 2703 of the inner cone 2701. A threaded section 2706 of the outer cone 2704 begins at an initial end 2709 and terminates at a final end 2710, and is threaded in a manner that allows for mating to a displacement nut 2708 which has matching internal threads. As the displacement nut 2708 is screwed forward from initial end 2709 to final end 2710, the leading edge of the displacement nut 2708 forces a fin or other finger-like member 2707 to be pushed down due to the inclined plane that comprises the rib 2713 of the fin 2707, and the sliding motion of the displacement nut 2708 as it rides over the fin 2707. A plurality of fins 2707 may be spaced circumferentially about the outer cone 2708 at the final end 2710 in order to affect the desired mechanism. This embodiment preferably has three fins spaced generally 120 degrees apart.
As seen in
The embodiment of
Delivery Method.
A number of methods may be used to deliver a prosthetic cardiac valve to the heart. Exemplary methods of delivering a prosthetic mitral valve may include a transluminal delivery route which may also be a transseptal technique which crosses the septum between the right and left sides of the heart, or in more preferred embodiments, a transapical route may be used such as illustrated in
As the outer sheath 1206 continues to be proximally retracted, the annular region of the prosthetic cardiac valve self-expands next into engagement with the valve annulus. The annular region also preferably has the D-shaped geometry, although it may also be cylindrical or have other geometries to match the native anatomy. In
In
Further actuation of the delivery device now retracts the outer sheath 1206 and the bell catheter shaft 1222 so as to remove the constraint from the hub catheter 1224, as illustrated in
As the outer sheath 1306 continues to be proximally retracted, the annular region of the prosthetic cardiac valve self-expands next into engagement with the valve annulus. The annular region also preferably has the D-shaped geometry, although it may also be cylindrical or have other geometries to match the native anatomy. In
In
Further actuation of the delivery device now retracts the outer sheath 1306 and the bell catheter shaft 1322 so as to remove the constraint from the hub catheter 1324, as illustrated in
While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.
The present application is a continuation of U.S. patent application Ser. No. 15/134,164, filed on Apr. 20, 2016, now U.S. patent Ser. No. TBD issued on TBD, which is a divisional of U.S. patent application Ser. No. 13/904,827, filed on May 29, 2013, now U.S. Pat. No. 9,345,573 issued on May 24, 2016, which claims the benefit of U.S. Provisional Application No. 61/653,273 filed on May 30, 2012, the entire contents of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3657744 | Robert | Apr 1972 | A |
3671979 | Spyridon | Jun 1972 | A |
3739402 | Kahn et al. | Jun 1973 | A |
4056854 | Boretos et al. | Nov 1977 | A |
4079468 | Liotta et al. | Mar 1978 | A |
4204283 | Bellhouse et al. | May 1980 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4265694 | Boretos et al. | May 1981 | A |
4339831 | Johnson | Jul 1982 | A |
4340977 | Brownlee et al. | Jul 1982 | A |
4470157 | Love | Sep 1984 | A |
4477930 | Totten et al. | Oct 1984 | A |
4490859 | Black et al. | Jan 1985 | A |
4553545 | Maass et al. | Nov 1985 | A |
4655771 | Wallsten et al. | Apr 1987 | A |
4733665 | Palmaz et al. | Mar 1988 | A |
4776337 | Palmaz et al. | Oct 1988 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4865600 | Carpentier et al. | Sep 1989 | A |
4950227 | Savin et al. | Aug 1990 | A |
4994077 | Dobben | Feb 1991 | A |
5067957 | Jervis | Nov 1991 | A |
5197978 | Hess et al. | Mar 1993 | A |
5326371 | Love et al. | Jul 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5344427 | Cottenceau et al. | Sep 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5397355 | Marin et al. | Mar 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5415667 | Frater | May 1995 | A |
5439446 | Barry | Aug 1995 | A |
5474563 | Myler et al. | Dec 1995 | A |
5509930 | Love | Apr 1996 | A |
5545214 | Stevens | Aug 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5575818 | Pinchuk | Nov 1996 | A |
5607444 | Lam | Mar 1997 | A |
5607469 | Frey | Mar 1997 | A |
5669919 | Sanders et al. | Sep 1997 | A |
5697382 | Love et al. | Dec 1997 | A |
D390957 | Fontaine | Feb 1998 | S |
5713952 | Vanney et al. | Feb 1998 | A |
5725519 | Penner et al. | Mar 1998 | A |
5769812 | Stevens et al. | Jun 1998 | A |
5807398 | Shaknovich | Sep 1998 | A |
5810873 | Morales | Sep 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5868777 | Lam | Feb 1999 | A |
5868782 | Frantzen | Feb 1999 | A |
5876437 | Vanney et al. | Mar 1999 | A |
5879381 | Moriuchi et al. | Mar 1999 | A |
5902334 | Dwyer et al. | May 1999 | A |
5928281 | Huynh et al. | Jul 1999 | A |
5935108 | Katoh et al. | Aug 1999 | A |
5954764 | Parodi | Sep 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5992000 | Humphrey et al. | Nov 1999 | A |
6004328 | Solar | Dec 1999 | A |
6015431 | Thornton et al. | Jan 2000 | A |
6042606 | Frantzen | Mar 2000 | A |
6053940 | Wijay | Apr 2000 | A |
6074417 | Peredo | Jun 2000 | A |
6082990 | Jackson | Jul 2000 | A |
6086612 | Jansen | Jul 2000 | A |
6113612 | Swanson et al. | Sep 2000 | A |
6113631 | Jansen | Sep 2000 | A |
6132458 | Staehle et al. | Oct 2000 | A |
6152937 | Peterson et al. | Nov 2000 | A |
6159237 | Alt et al. | Dec 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6168616 | Brown, III | Jan 2001 | B1 |
6251093 | Valley et al. | Jun 2001 | B1 |
6280466 | Kugler et al. | Aug 2001 | B1 |
6306141 | Jervis | Oct 2001 | B1 |
6312465 | Griffin et al. | Nov 2001 | B1 |
6336938 | Kavteladze et al. | Jan 2002 | B1 |
6352543 | Cole | Mar 2002 | B1 |
6358277 | Duran | Mar 2002 | B1 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6440164 | DiMatteo et al. | Aug 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6475237 | Drasler et al. | Nov 2002 | B2 |
6482228 | Norred | Nov 2002 | B1 |
6511491 | Grudem et al. | Jan 2003 | B2 |
6517573 | Pollock et al. | Feb 2003 | B1 |
6527800 | McGuckin, Jr. et al. | Mar 2003 | B1 |
6551303 | Van Tassel et al. | Apr 2003 | B1 |
6582462 | Andersen et al. | Jun 2003 | B1 |
6602281 | Klein | Aug 2003 | B1 |
6610088 | Gabbay | Aug 2003 | B1 |
6629534 | St. Goar et al. | Oct 2003 | B1 |
6641606 | Ouriel et al. | Nov 2003 | B2 |
6652578 | Bailey et al. | Nov 2003 | B2 |
D484979 | Fontaine | Jan 2004 | S |
6676698 | McGuckin et al. | Jan 2004 | B2 |
6682537 | Ouriel et al. | Jan 2004 | B2 |
6695878 | McGuckin et al. | Feb 2004 | B2 |
6712836 | Berg et al. | Mar 2004 | B1 |
6723123 | Kazatchkov et al. | Apr 2004 | B1 |
6730118 | Spenser et al. | May 2004 | B2 |
6733523 | Shaolian et al. | May 2004 | B2 |
6764505 | Hossainy et al. | Jul 2004 | B1 |
6767362 | Schreck | Jul 2004 | B2 |
6780200 | Jansen | Aug 2004 | B2 |
6790229 | Berreklouw | Sep 2004 | B1 |
6790230 | Beyersdorf et al. | Sep 2004 | B2 |
6814746 | Thompson et al. | Nov 2004 | B2 |
6858034 | Hijlkema et al. | Feb 2005 | B1 |
6875231 | Anduiza et al. | Apr 2005 | B2 |
6893460 | Spenser et al. | May 2005 | B2 |
6908477 | McGuckin et al. | Jun 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
6926732 | Derus et al. | Aug 2005 | B2 |
6929660 | Ainsworth et al. | Aug 2005 | B1 |
6936058 | Forde et al. | Aug 2005 | B2 |
6979350 | Moll et al. | Dec 2005 | B2 |
7014653 | Ouriel et al. | Mar 2006 | B2 |
7018401 | Hyodoh et al. | Mar 2006 | B1 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7025780 | Gabbay | Apr 2006 | B2 |
7044962 | Elliot et al. | May 2006 | B2 |
7044966 | Svanidze et al. | May 2006 | B2 |
7087088 | Berg et al. | Aug 2006 | B2 |
7147660 | Chobotov et al. | Dec 2006 | B2 |
7147661 | Chobotov et al. | Dec 2006 | B2 |
7147663 | Berg et al. | Dec 2006 | B1 |
7153322 | Alt | Dec 2006 | B2 |
7186265 | Sharkawy et al. | Mar 2007 | B2 |
7198646 | Figulla et al. | Apr 2007 | B2 |
7201772 | Schwammenthal et al. | Apr 2007 | B2 |
7252682 | Seguin | Aug 2007 | B2 |
D553747 | Fliedner | Oct 2007 | S |
7276078 | Spenser et al. | Oct 2007 | B2 |
7276084 | Yang et al. | Oct 2007 | B2 |
7311730 | Gabbay | Dec 2007 | B2 |
7329278 | Seguin et al. | Feb 2008 | B2 |
7377938 | Sarac et al. | May 2008 | B2 |
7381210 | Zarbatany et al. | Jun 2008 | B2 |
7381219 | Salahieh et al. | Jun 2008 | B2 |
7393360 | Spenser et al. | Jul 2008 | B2 |
7422603 | Lane | Sep 2008 | B2 |
7429269 | Schwammenthal et al. | Sep 2008 | B2 |
7442204 | Schwammenthal et al. | Oct 2008 | B2 |
7445631 | Haug et al. | Nov 2008 | B2 |
7455689 | Johnson | Nov 2008 | B2 |
7462191 | Spenser et al. | Dec 2008 | B2 |
7510572 | Gabbay | Mar 2009 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7524330 | Berreklouw | Apr 2009 | B2 |
7527646 | Rahdert et al. | May 2009 | B2 |
7534259 | Lashinski et al. | May 2009 | B2 |
7534261 | Friedman | May 2009 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7608114 | Levine et al. | Oct 2009 | B2 |
7615072 | Rust et al. | Nov 2009 | B2 |
7618446 | Andersen et al. | Nov 2009 | B2 |
7618447 | Case et al. | Nov 2009 | B2 |
7621948 | Herrmann et al. | Nov 2009 | B2 |
7628805 | Spenser et al. | Dec 2009 | B2 |
7632298 | Hijlkema et al. | Dec 2009 | B2 |
7637945 | Solem et al. | Dec 2009 | B2 |
7637946 | Solem et al. | Dec 2009 | B2 |
7682390 | Seguin | Mar 2010 | B2 |
7708775 | Rowe et al. | May 2010 | B2 |
7712606 | Salahieh et al. | May 2010 | B2 |
7748389 | Salahieh et al. | Jul 2010 | B2 |
7753949 | Lamphere et al. | Jul 2010 | B2 |
D622387 | Igaki | Aug 2010 | S |
D622388 | Igaki | Aug 2010 | S |
7771463 | Ton et al. | Aug 2010 | B2 |
7771472 | Hendricksen et al. | Aug 2010 | B2 |
7780725 | Haug et al. | Aug 2010 | B2 |
7785360 | Freitag | Aug 2010 | B2 |
7803185 | Gabbay | Sep 2010 | B2 |
7806917 | Xiao | Oct 2010 | B2 |
7806919 | Bloom et al. | Oct 2010 | B2 |
7815589 | Meade et al. | Oct 2010 | B2 |
7815673 | Bloom et al. | Oct 2010 | B2 |
7824443 | Salahieh et al. | Nov 2010 | B2 |
7837727 | Goetz et al. | Nov 2010 | B2 |
7846203 | Cribier | Dec 2010 | B2 |
7871435 | Carpentier et al. | Jan 2011 | B2 |
7892281 | Seguin et al. | Feb 2011 | B2 |
D635261 | Rossi | Mar 2011 | S |
D635262 | Rossi | Mar 2011 | S |
7896915 | Guyenot et al. | Mar 2011 | B2 |
7914569 | Nguyen et al. | Mar 2011 | B2 |
7919112 | Pathak et al. | Apr 2011 | B2 |
7947075 | Goetz et al. | May 2011 | B2 |
7959672 | Salahieh et al. | Jun 2011 | B2 |
7967853 | Eidenschink et al. | Jun 2011 | B2 |
7972377 | Lane | Jul 2011 | B2 |
7972378 | Tabor et al. | Jul 2011 | B2 |
7981151 | Rowe | Jul 2011 | B2 |
7993392 | Righini et al. | Aug 2011 | B2 |
7993394 | Hariton et al. | Aug 2011 | B2 |
7993395 | Vanermen et al. | Aug 2011 | B2 |
7998196 | Mathison | Aug 2011 | B2 |
8009887 | Ionasec et al. | Aug 2011 | B2 |
8016870 | Chew et al. | Sep 2011 | B2 |
8016877 | Seguin et al. | Sep 2011 | B2 |
8029564 | Johnson et al. | Oct 2011 | B2 |
8034104 | Carpentier et al. | Oct 2011 | B2 |
8048153 | Salahieh et al. | Nov 2011 | B2 |
8052747 | Melnikov et al. | Nov 2011 | B2 |
8052749 | Salahieh et al. | Nov 2011 | B2 |
8052750 | Tuval et al. | Nov 2011 | B2 |
8057538 | Bergin et al. | Nov 2011 | B2 |
8057539 | Ghione et al. | Nov 2011 | B2 |
8057540 | Letac et al. | Nov 2011 | B2 |
8062350 | Gale et al. | Nov 2011 | B2 |
8062355 | Figulla et al. | Nov 2011 | B2 |
8062359 | Marquez et al. | Nov 2011 | B2 |
8066755 | Zacharias et al. | Nov 2011 | B2 |
8066763 | Alt | Nov 2011 | B2 |
8070743 | Kagan et al. | Dec 2011 | B2 |
8070799 | Righini et al. | Dec 2011 | B2 |
8070800 | Lock et al. | Dec 2011 | B2 |
8070801 | Cohn | Dec 2011 | B2 |
8070802 | Lamphere et al. | Dec 2011 | B2 |
8075609 | Penn et al. | Dec 2011 | B2 |
8075611 | Millwee et al. | Dec 2011 | B2 |
8075615 | Eberhardt et al. | Dec 2011 | B2 |
8078279 | Dennis et al. | Dec 2011 | B2 |
8080054 | Rowe | Dec 2011 | B2 |
8083793 | Lane et al. | Dec 2011 | B2 |
8088158 | Brodeur | Jan 2012 | B2 |
8088404 | Udipi et al. | Jan 2012 | B2 |
8092520 | Quadri | Jan 2012 | B2 |
8100964 | Spence | Jan 2012 | B2 |
8105375 | Navia et al. | Jan 2012 | B2 |
8105377 | Liddicoat | Jan 2012 | B2 |
8109995 | Paniagua et al. | Feb 2012 | B2 |
8109996 | Stacchino et al. | Feb 2012 | B2 |
8114154 | Righini et al. | Feb 2012 | B2 |
8118866 | Herrmann et al. | Feb 2012 | B2 |
8119704 | Wang et al. | Feb 2012 | B2 |
8123801 | Milo | Feb 2012 | B2 |
8128681 | Shoemaker et al. | Mar 2012 | B2 |
8128688 | Ding et al. | Mar 2012 | B2 |
8136218 | Millwee et al. | Mar 2012 | B2 |
8137398 | Tuval et al. | Mar 2012 | B2 |
8137687 | Chen et al. | Mar 2012 | B2 |
8142492 | Forster et al. | Mar 2012 | B2 |
8142494 | Rahdert et al. | Mar 2012 | B2 |
8147504 | Ino et al. | Apr 2012 | B2 |
8155754 | Nygren et al. | Apr 2012 | B2 |
8157852 | Bloom et al. | Apr 2012 | B2 |
8157853 | Laske et al. | Apr 2012 | B2 |
8158187 | Chen et al. | Apr 2012 | B2 |
8163014 | Lane et al. | Apr 2012 | B2 |
8167926 | Hartley et al. | May 2012 | B2 |
8167932 | Bourang et al. | May 2012 | B2 |
8167934 | Styrc et al. | May 2012 | B2 |
8168275 | Lee et al. | May 2012 | B2 |
8170645 | Solar et al. | May 2012 | B2 |
8177799 | Orban, III | May 2012 | B2 |
8177836 | Lee et al. | May 2012 | B2 |
8180428 | Kaiser et al. | May 2012 | B2 |
8182528 | Salahieh et al. | May 2012 | B2 |
8182530 | Huber et al. | May 2012 | B2 |
8182829 | Kleiner et al. | May 2012 | B2 |
8187851 | Shah et al. | May 2012 | B2 |
8195293 | Limousin et al. | Jun 2012 | B2 |
8202529 | Hossainy et al. | Jun 2012 | B2 |
8211169 | Lane et al. | Jul 2012 | B2 |
8216261 | Solem et al. | Jul 2012 | B2 |
8216301 | Bonhoeffer et al. | Jul 2012 | B2 |
8219229 | Cao et al. | Jul 2012 | B2 |
8220121 | Hendriksen et al. | Jul 2012 | B2 |
8221482 | Cottone et al. | Jul 2012 | B2 |
8221493 | Bailey et al. | Jul 2012 | B2 |
8226666 | Zarbatany et al. | Jul 2012 | B2 |
8226710 | Nguyen et al. | Jul 2012 | B2 |
8231930 | Castro et al. | Jul 2012 | B2 |
D665079 | Zago | Aug 2012 | S |
D665080 | Zago | Aug 2012 | S |
8236045 | Benichou et al. | Aug 2012 | B2 |
8236241 | Carpentier et al. | Aug 2012 | B2 |
8241274 | Keogh et al. | Aug 2012 | B2 |
8246675 | Zegdi | Aug 2012 | B2 |
8246677 | Ryan | Aug 2012 | B2 |
8246678 | Haug et al. | Aug 2012 | B2 |
8252051 | Chau et al. | Aug 2012 | B2 |
8252052 | Salahieh et al. | Aug 2012 | B2 |
8257724 | Cromack et al. | Sep 2012 | B2 |
8257725 | Cromack et al. | Sep 2012 | B2 |
8262724 | Seguin et al. | Sep 2012 | B2 |
8273118 | Bergin | Sep 2012 | B2 |
8273120 | Dolan | Sep 2012 | B2 |
8276533 | Chambers et al. | Oct 2012 | B2 |
8287584 | Salahieh et al. | Oct 2012 | B2 |
8287591 | Keidar et al. | Oct 2012 | B2 |
8303653 | Bonhoeffer et al. | Nov 2012 | B2 |
8308798 | Pintor et al. | Nov 2012 | B2 |
8313520 | Barbut et al. | Nov 2012 | B2 |
8313525 | Tuval et al. | Nov 2012 | B2 |
8317854 | Ryan et al. | Nov 2012 | B1 |
8323335 | Rowe et al. | Dec 2012 | B2 |
8323336 | Hill et al. | Dec 2012 | B2 |
8337541 | Quadri et al. | Dec 2012 | B2 |
8348995 | Tuval et al. | Jan 2013 | B2 |
8349001 | Mensah et al. | Jan 2013 | B2 |
8349003 | Shu et al. | Jan 2013 | B2 |
8353921 | Schaller et al. | Jan 2013 | B2 |
8353948 | Besselink et al. | Jan 2013 | B2 |
8353953 | Giannetti et al. | Jan 2013 | B2 |
8353954 | Cai et al. | Jan 2013 | B2 |
8357387 | Dove et al. | Jan 2013 | B2 |
8361137 | Perouse | Jan 2013 | B2 |
8361537 | Shanley | Jan 2013 | B2 |
8366769 | Huynh et al. | Feb 2013 | B2 |
8377116 | Hsu et al. | Feb 2013 | B2 |
8377499 | Kleiner et al. | Feb 2013 | B2 |
8382816 | Pollock et al. | Feb 2013 | B2 |
RE44075 | Williamson et al. | Mar 2013 | E |
8398707 | Bergin | Mar 2013 | B2 |
8398708 | Meiri et al. | Mar 2013 | B2 |
8403983 | Quadri et al. | Mar 2013 | B2 |
8408214 | Spenser | Apr 2013 | B2 |
8409274 | Li et al. | Apr 2013 | B2 |
8414635 | Hyodoh et al. | Apr 2013 | B2 |
8414643 | Tuval et al. | Apr 2013 | B2 |
8414644 | Quadri | Apr 2013 | B2 |
8414645 | Dwork et al. | Apr 2013 | B2 |
8430902 | Bergheim | Apr 2013 | B2 |
8430927 | Bonhoeffer | Apr 2013 | B2 |
8444689 | Zhang | May 2013 | B2 |
8449466 | Duhay et al. | May 2013 | B2 |
8449599 | Chau et al. | May 2013 | B2 |
8449625 | Campbell et al. | May 2013 | B2 |
8454684 | Bergin et al. | Jun 2013 | B2 |
8454685 | Hariton et al. | Jun 2013 | B2 |
8460335 | Carpenter | Jun 2013 | B2 |
8460365 | Haverkost et al. | Jun 2013 | B2 |
8460366 | Rowe et al. | Jun 2013 | B2 |
8460370 | Zakay et al. | Jun 2013 | B2 |
8460373 | Fogarty et al. | Jun 2013 | B2 |
8468667 | Straubinger | Jun 2013 | B2 |
8470023 | Eidenschink et al. | Jun 2013 | B2 |
8470024 | Ghione et al. | Jun 2013 | B2 |
8475521 | Suri et al. | Jul 2013 | B2 |
8475522 | Jimenez et al. | Jul 2013 | B2 |
8475523 | Duffy | Jul 2013 | B2 |
8479380 | Malewicz et al. | Jul 2013 | B2 |
8480730 | Maurer et al. | Jul 2013 | B2 |
8480731 | Elizondo et al. | Jul 2013 | B2 |
8486137 | Suri et al. | Jul 2013 | B2 |
8491650 | Wiemeyer et al. | Jul 2013 | B2 |
8500688 | Engel et al. | Aug 2013 | B2 |
8500755 | Ino et al. | Aug 2013 | B2 |
8500798 | Rowe et al. | Aug 2013 | B2 |
8500801 | Eberhardt et al. | Aug 2013 | B2 |
8500802 | Lane et al. | Aug 2013 | B2 |
8506620 | Ryan | Aug 2013 | B2 |
8506625 | Johnson | Aug 2013 | B2 |
8511244 | Holecek et al. | Aug 2013 | B2 |
8512397 | Rolando et al. | Aug 2013 | B2 |
8512398 | Alkhatib | Aug 2013 | B2 |
8512399 | Lafontaine | Aug 2013 | B2 |
8512401 | Murray, III et al. | Aug 2013 | B2 |
8512403 | Navia et al. | Aug 2013 | B2 |
8518106 | Duffy et al. | Aug 2013 | B2 |
8518108 | Huynh et al. | Aug 2013 | B2 |
8529621 | Alfieri et al. | Sep 2013 | B2 |
8535368 | Headley et al. | Sep 2013 | B2 |
8539662 | Stacchino et al. | Sep 2013 | B2 |
8545742 | Gada et al. | Oct 2013 | B2 |
8551162 | Fogarty et al. | Oct 2013 | B2 |
8562663 | Mearns et al. | Oct 2013 | B2 |
8562672 | Bonhoeffer et al. | Oct 2013 | B2 |
8562673 | Yeung et al. | Oct 2013 | B2 |
8565872 | Pederson | Oct 2013 | B2 |
8568472 | Marchand et al. | Oct 2013 | B2 |
8579964 | Lane et al. | Nov 2013 | B2 |
8579965 | Bonhoeffer et al. | Nov 2013 | B2 |
8584849 | McCaffrey | Nov 2013 | B2 |
8585749 | Shelso | Nov 2013 | B2 |
8585755 | Chau et al. | Nov 2013 | B2 |
8585756 | Bonhoeffer et al. | Nov 2013 | B2 |
8591570 | Revuelta et al. | Nov 2013 | B2 |
8591574 | Lambrecht et al. | Nov 2013 | B2 |
8597348 | Rowe et al. | Dec 2013 | B2 |
8603154 | Strauss et al. | Dec 2013 | B2 |
8603160 | Salahieh et al. | Dec 2013 | B2 |
8603161 | Drews et al. | Dec 2013 | B2 |
8608648 | Banik et al. | Dec 2013 | B2 |
8608797 | Gross et al. | Dec 2013 | B2 |
8617236 | Paul et al. | Dec 2013 | B2 |
8623074 | Ryan | Jan 2014 | B2 |
8623079 | Savage et al. | Jan 2014 | B2 |
8623080 | Fogarty et al. | Jan 2014 | B2 |
8628566 | Eberhardt et al. | Jan 2014 | B2 |
8632586 | Spenser et al. | Jan 2014 | B2 |
8632608 | Carpentier et al. | Jan 2014 | B2 |
8640521 | Righini et al. | Feb 2014 | B2 |
8641639 | Manstrom et al. | Feb 2014 | B2 |
8647381 | Essinger et al. | Feb 2014 | B2 |
8652201 | Oberti et al. | Feb 2014 | B2 |
8652202 | Alon et al. | Feb 2014 | B2 |
8652203 | Quadri et al. | Feb 2014 | B2 |
8653632 | Pederson et al. | Feb 2014 | B2 |
8663318 | Ho | Mar 2014 | B2 |
8663319 | Ho | Mar 2014 | B2 |
8668730 | McGuckin, Jr. et al. | Mar 2014 | B2 |
8668733 | Salahieh et al. | Mar 2014 | B2 |
8672992 | Orr | Mar 2014 | B2 |
8672997 | Drasler et al. | Mar 2014 | B2 |
8672998 | Lichtenstein et al. | Mar 2014 | B2 |
8672999 | Cali et al. | Mar 2014 | B2 |
8673000 | Tabor et al. | Mar 2014 | B2 |
8679174 | Ottma et al. | Mar 2014 | B2 |
8679404 | Liburd et al. | Mar 2014 | B2 |
8685083 | Perier et al. | Apr 2014 | B2 |
8685086 | Navia et al. | Apr 2014 | B2 |
8690787 | Blomqvist et al. | Apr 2014 | B2 |
8690936 | Nguyen et al. | Apr 2014 | B2 |
8696742 | Pintor et al. | Apr 2014 | B2 |
8707957 | Callister et al. | Apr 2014 | B2 |
8715207 | Righini et al. | May 2014 | B2 |
8715337 | Chuter et al. | May 2014 | B2 |
8715343 | Navia et al. | May 2014 | B2 |
8721707 | Boucher et al. | May 2014 | B2 |
8721708 | Sequin et al. | May 2014 | B2 |
8721713 | Tower et al. | May 2014 | B2 |
8721714 | Kelley | May 2014 | B2 |
8728154 | Alkhatib | May 2014 | B2 |
8728155 | Montorfano et al. | May 2014 | B2 |
8731658 | Hampton et al. | May 2014 | B2 |
8734484 | Ahlberg et al. | May 2014 | B2 |
8740930 | Goodwin | Jun 2014 | B2 |
8740974 | Lambrecht et al. | Jun 2014 | B2 |
8740975 | Yang et al. | Jun 2014 | B2 |
8740976 | Tran et al. | Jun 2014 | B2 |
8747458 | Tuval et al. | Jun 2014 | B2 |
8747459 | Nguyen et al. | Jun 2014 | B2 |
8747460 | Tuval et al. | Jun 2014 | B2 |
8753384 | Leanna | Jun 2014 | B2 |
8758432 | Solem et al. | Jun 2014 | B2 |
8764814 | Solem | Jul 2014 | B2 |
8764820 | Dehdashtian et al. | Jul 2014 | B2 |
8771302 | Woolfson et al. | Jul 2014 | B2 |
8771344 | Tran et al. | Jul 2014 | B2 |
8771345 | Tuval et al. | Jul 2014 | B2 |
8771346 | Tuval et al. | Jul 2014 | B2 |
8777975 | Kashkarov et al. | Jul 2014 | B2 |
8778018 | Iobbi | Jul 2014 | B2 |
8784478 | Tuval et al. | Jul 2014 | B2 |
8784480 | Taylor et al. | Jul 2014 | B2 |
8784481 | Alkhatib et al. | Jul 2014 | B2 |
8790387 | Nguyen et al. | Jul 2014 | B2 |
8790395 | Straubinger et al. | Jul 2014 | B2 |
8790396 | Bergheim et al. | Jul 2014 | B2 |
8791171 | Pacetti et al. | Jul 2014 | B2 |
8795356 | Quadri et al. | Aug 2014 | B2 |
8801776 | House et al. | Aug 2014 | B2 |
8808366 | Braido et al. | Aug 2014 | B2 |
8808370 | Nitzan et al. | Aug 2014 | B2 |
8821569 | Gurskis et al. | Sep 2014 | B2 |
8821570 | Dumontelle et al. | Sep 2014 | B2 |
8828078 | Salahieh et al. | Sep 2014 | B2 |
8828079 | Thielen et al. | Sep 2014 | B2 |
8834561 | Figulla et al. | Sep 2014 | B2 |
8834564 | Tuval et al. | Sep 2014 | B2 |
8840661 | Manasse | Sep 2014 | B2 |
8845718 | Tuval et al. | Sep 2014 | B2 |
8845720 | Conklin | Sep 2014 | B2 |
8852267 | Cattaneo | Oct 2014 | B2 |
8858620 | Salahieh et al. | Oct 2014 | B2 |
8858621 | Oba et al. | Oct 2014 | B2 |
8870936 | Rowe | Oct 2014 | B2 |
8870947 | Shaw | Oct 2014 | B2 |
8870948 | Erzberger et al. | Oct 2014 | B1 |
8876712 | Yee et al. | Nov 2014 | B2 |
8876883 | Rust | Nov 2014 | B2 |
8876893 | Dwork et al. | Nov 2014 | B2 |
8876894 | Tuval et al. | Nov 2014 | B2 |
8876895 | Tuval et al. | Nov 2014 | B2 |
8882831 | Alkhatib | Nov 2014 | B2 |
8894702 | Quadri et al. | Nov 2014 | B2 |
8894703 | Salahieh et al. | Nov 2014 | B2 |
8906081 | Cully et al. | Dec 2014 | B2 |
8911455 | Quadri et al. | Dec 2014 | B2 |
8911844 | Ford | Dec 2014 | B2 |
8926688 | Burkart et al. | Jan 2015 | B2 |
8926693 | Duffy et al. | Jan 2015 | B2 |
8932349 | Jenson et al. | Jan 2015 | B2 |
8940887 | Chatterton et al. | Jan 2015 | B2 |
8945208 | Jimenez et al. | Feb 2015 | B2 |
8945209 | Bonyuet et al. | Feb 2015 | B2 |
8945210 | Cartledge et al. | Feb 2015 | B2 |
8951280 | Cohn et al. | Feb 2015 | B2 |
8951299 | Paul et al. | Feb 2015 | B2 |
8961583 | Hojeibane et al. | Feb 2015 | B2 |
8961589 | Kleiner et al. | Feb 2015 | B2 |
8961593 | Bonhoeffer et al. | Feb 2015 | B2 |
8961595 | Alkhatib | Feb 2015 | B2 |
8968393 | Rothstein | Mar 2015 | B2 |
8968395 | Hauser et al. | Mar 2015 | B2 |
8974524 | Yeung et al. | Mar 2015 | B2 |
8979922 | Thambar et al. | Mar 2015 | B2 |
8986372 | Murry, III et al. | Mar 2015 | B2 |
8986713 | Cleek et al. | Mar 2015 | B2 |
8992608 | Salahieh et al. | Mar 2015 | B2 |
8998978 | Wang | Apr 2015 | B2 |
8998979 | Seguin et al. | Apr 2015 | B2 |
8998980 | Shipley et al. | Apr 2015 | B2 |
8998981 | Tuval et al. | Apr 2015 | B2 |
8999369 | Gale et al. | Apr 2015 | B2 |
9005273 | Salahieh et al. | Apr 2015 | B2 |
9005277 | Pintor et al. | Apr 2015 | B2 |
9011521 | Haug et al. | Apr 2015 | B2 |
9011523 | Seguin | Apr 2015 | B2 |
9011524 | Eberhardt | Apr 2015 | B2 |
9011528 | Ryan et al. | Apr 2015 | B2 |
9023100 | Quadri et al. | May 2015 | B2 |
9028545 | Taylor | May 2015 | B2 |
9029418 | Dove et al. | May 2015 | B2 |
9034032 | McLean et al. | May 2015 | B2 |
9034033 | McLean et al. | May 2015 | B2 |
9055937 | Rowe et al. | Jun 2015 | B2 |
9072603 | Tuval et al. | Jul 2015 | B2 |
9078749 | Lutter et al. | Jul 2015 | B2 |
9078751 | Naor | Jul 2015 | B2 |
9084676 | Chau et al. | Jul 2015 | B2 |
9125738 | Figulla et al. | Sep 2015 | B2 |
9138312 | Tuval et al. | Sep 2015 | B2 |
9161834 | Taylor et al. | Oct 2015 | B2 |
D755384 | Pesce et al. | May 2016 | S |
9333074 | Quadri et al. | May 2016 | B2 |
9345573 | Nyuli | May 2016 | B2 |
9554897 | Lane et al. | Jan 2017 | B2 |
9770329 | Lane et al. | Sep 2017 | B2 |
20010007956 | Letac et al. | Jul 2001 | A1 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20010045539 | Doyle | Nov 2001 | A1 |
20010047180 | Grudem et al. | Nov 2001 | A1 |
20010047200 | White et al. | Nov 2001 | A1 |
20020016623 | Kula et al. | Feb 2002 | A1 |
20020022853 | Swanson et al. | Feb 2002 | A1 |
20020032481 | Gabbay | Mar 2002 | A1 |
20020045929 | Diaz | Apr 2002 | A1 |
20020052644 | Shaolian et al. | May 2002 | A1 |
20020055772 | McGuckin et al. | May 2002 | A1 |
20020111619 | Keast et al. | Aug 2002 | A1 |
20020177899 | Eum | Nov 2002 | A1 |
20020183827 | Derus et al. | Dec 2002 | A1 |
20020198584 | Unsworth | Dec 2002 | A1 |
20030040792 | Gabbay | Feb 2003 | A1 |
20030105517 | White et al. | Jun 2003 | A1 |
20030114913 | Spenser et al. | Jun 2003 | A1 |
20030120263 | Ouriel et al. | Jun 2003 | A1 |
20030120330 | Ouriel et al. | Jun 2003 | A1 |
20030120333 | Ouriel et al. | Jun 2003 | A1 |
20030125797 | Chobotov et al. | Jul 2003 | A1 |
20030130729 | Paniagua et al. | Jul 2003 | A1 |
20030135970 | Thornton | Jul 2003 | A1 |
20030176914 | Rabkin et al. | Sep 2003 | A1 |
20030199971 | Tower et al. | Oct 2003 | A1 |
20030220683 | Minasian et al. | Nov 2003 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040087900 | Thompson et al. | May 2004 | A1 |
20040093058 | Cottone et al. | May 2004 | A1 |
20040093060 | Seguin et al. | May 2004 | A1 |
20040102842 | Jansen | May 2004 | A1 |
20040117009 | Cali et al. | Jun 2004 | A1 |
20040133273 | Cox | Jul 2004 | A1 |
20040181238 | Zarbatany et al. | Sep 2004 | A1 |
20040186561 | McGuckin et al. | Sep 2004 | A1 |
20040193261 | Berreklouw | Sep 2004 | A1 |
20040210304 | Seguin et al. | Oct 2004 | A1 |
20040210307 | Khairkhahan | Oct 2004 | A1 |
20040215325 | Penn et al. | Oct 2004 | A1 |
20040225353 | McGuckin et al. | Nov 2004 | A1 |
20040236411 | Sarac et al. | Nov 2004 | A1 |
20040243230 | Navia et al. | Dec 2004 | A1 |
20040249433 | Freitag | Dec 2004 | A1 |
20040260390 | Sarac et al. | Dec 2004 | A1 |
20050033398 | Seguin | Feb 2005 | A1 |
20050038470 | Van Der Burg et al. | Feb 2005 | A1 |
20050075727 | Wheatley | Apr 2005 | A1 |
20050090887 | Pryor | Apr 2005 | A1 |
20050096738 | Cali et al. | May 2005 | A1 |
20050107872 | Mensah et al. | May 2005 | A1 |
20050125020 | Meade et al. | Jun 2005 | A1 |
20050137682 | Justino | Jun 2005 | A1 |
20050137686 | Salahieh et al. | Jun 2005 | A1 |
20050137687 | Salahieh et al. | Jun 2005 | A1 |
20050137690 | Salahieh et al. | Jun 2005 | A1 |
20050137691 | Salahieh et al. | Jun 2005 | A1 |
20050137693 | Haug et al. | Jun 2005 | A1 |
20050137695 | Salahieh et al. | Jun 2005 | A1 |
20050137701 | Salahieh et al. | Jun 2005 | A1 |
20050154444 | Quadri | Jul 2005 | A1 |
20050159811 | Lane | Jul 2005 | A1 |
20050182483 | Osborne et al. | Aug 2005 | A1 |
20050182486 | Gabbay | Aug 2005 | A1 |
20050203616 | Cribier | Sep 2005 | A1 |
20050216079 | MaCoviak | Sep 2005 | A1 |
20050234546 | Nugent et al. | Oct 2005 | A1 |
20050283231 | Haug et al. | Dec 2005 | A1 |
20060020247 | Kagan et al. | Jan 2006 | A1 |
20060020327 | Lashinski et al. | Jan 2006 | A1 |
20060020334 | Lashinski et al. | Jan 2006 | A1 |
20060052802 | Sterman et al. | Mar 2006 | A1 |
20060052867 | Revuelta et al. | Mar 2006 | A1 |
20060058872 | Salahieh et al. | Mar 2006 | A1 |
20060064120 | Levine et al. | Mar 2006 | A1 |
20060095115 | Bladillah et al. | May 2006 | A1 |
20060106454 | Osborne et al. | May 2006 | A1 |
20060116625 | Renati et al. | Jun 2006 | A1 |
20060129235 | Seguin et al. | Jun 2006 | A1 |
20060149360 | Schwammenthal et al. | Jul 2006 | A1 |
20060161265 | Levine et al. | Jul 2006 | A1 |
20060173537 | Yang et al. | Aug 2006 | A1 |
20060195183 | Navia et al. | Aug 2006 | A1 |
20060212110 | Osborne et al. | Sep 2006 | A1 |
20060224232 | Chobotov | Oct 2006 | A1 |
20060241745 | Solem | Oct 2006 | A1 |
20060253191 | Salahieh et al. | Nov 2006 | A1 |
20060259135 | Navia et al. | Nov 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060265056 | Nguyen et al. | Nov 2006 | A1 |
20060287717 | Rowe et al. | Dec 2006 | A1 |
20060287719 | Rowe et al. | Dec 2006 | A1 |
20060293698 | Douk | Dec 2006 | A1 |
20060293745 | Carpentier et al. | Dec 2006 | A1 |
20070010876 | Salahieh et al. | Jan 2007 | A1 |
20070016286 | Herrmann et al. | Jan 2007 | A1 |
20070043435 | Seguin et al. | Feb 2007 | A1 |
20070050020 | Spence | Mar 2007 | A1 |
20070050021 | Johnson | Mar 2007 | A1 |
20070067016 | Jung | Mar 2007 | A1 |
20070100432 | Case et al. | May 2007 | A1 |
20070118206 | Colgan et al. | May 2007 | A1 |
20070118207 | Amplatz et al. | May 2007 | A1 |
20070129794 | Realyvasquez | Jun 2007 | A1 |
20070142906 | Figulla et al. | Jun 2007 | A1 |
20070162107 | Haug et al. | Jul 2007 | A1 |
20070185559 | Shelso | Aug 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070219620 | Eells et al. | Sep 2007 | A1 |
20070233228 | Eberhardt et al. | Oct 2007 | A1 |
20070250151 | Pereira | Oct 2007 | A1 |
20070255391 | Hojeibane et al. | Nov 2007 | A1 |
20070255394 | Ryan | Nov 2007 | A1 |
20070265656 | Amplatz et al. | Nov 2007 | A1 |
20070270932 | Headley et al. | Nov 2007 | A1 |
20070270937 | Leanna | Nov 2007 | A1 |
20070293940 | Schaeffer et al. | Dec 2007 | A1 |
20080009934 | Schneider et al. | Jan 2008 | A1 |
20080021546 | Patz et al. | Jan 2008 | A1 |
20080022504 | Melsheimer | Jan 2008 | A1 |
20080053577 | Syed et al. | Mar 2008 | A1 |
20080071361 | Tuval et al. | Mar 2008 | A1 |
20080071363 | Tuval et al. | Mar 2008 | A1 |
20080071366 | Tuval et al. | Mar 2008 | A1 |
20080071369 | Tuval et al. | Mar 2008 | A1 |
20080082164 | Friedman | Apr 2008 | A1 |
20080082165 | Wilson et al. | Apr 2008 | A1 |
20080082166 | Styrc et al. | Apr 2008 | A1 |
20080087581 | Eisenhut et al. | Apr 2008 | A1 |
20080097571 | Denison et al. | Apr 2008 | A1 |
20080114441 | Rust et al. | May 2008 | A1 |
20080125853 | Bailey et al. | May 2008 | A1 |
20080125859 | Salahieh et al. | May 2008 | A1 |
20080127707 | Kokish et al. | Jun 2008 | A1 |
20080133003 | Seguin et al. | Jun 2008 | A1 |
20080140189 | Nguyen et al. | Jun 2008 | A1 |
20080147179 | Cai et al. | Jun 2008 | A1 |
20080147183 | Styrc | Jun 2008 | A1 |
20080154358 | Tansley et al. | Jun 2008 | A1 |
20080161911 | Revuelta et al. | Jul 2008 | A1 |
20080177381 | Navia et al. | Jul 2008 | A1 |
20080183273 | Mesana et al. | Jul 2008 | A1 |
20080208307 | Ben-Muvhar et al. | Aug 2008 | A1 |
20080208328 | Antocci et al. | Aug 2008 | A1 |
20080208332 | Lamphere et al. | Aug 2008 | A1 |
20080221672 | Lamphere et al. | Sep 2008 | A1 |
20080228201 | Zarbatany et al. | Sep 2008 | A1 |
20080228254 | Ryan | Sep 2008 | A1 |
20080243233 | Ben-Muvhar et al. | Oct 2008 | A1 |
20080243245 | Thambar et al. | Oct 2008 | A1 |
20080255660 | Guyenot et al. | Oct 2008 | A1 |
20080255661 | Straubinger et al. | Oct 2008 | A1 |
20080262596 | Xiao | Oct 2008 | A1 |
20080262603 | Giaquinta et al. | Oct 2008 | A1 |
20080269878 | Iobbi | Oct 2008 | A1 |
20080275549 | Rowe | Nov 2008 | A1 |
20080288062 | Andrieu et al. | Nov 2008 | A1 |
20080319526 | Hill et al. | Dec 2008 | A1 |
20090005863 | Goetz et al. | Jan 2009 | A1 |
20090012602 | Quadri | Jan 2009 | A1 |
20090054976 | Tuval et al. | Feb 2009 | A1 |
20090062908 | Bonhoeffer et al. | Mar 2009 | A1 |
20090076531 | Richardson et al. | Mar 2009 | A1 |
20090076585 | Hendriksen et al. | Mar 2009 | A1 |
20090076598 | Salahieh et al. | Mar 2009 | A1 |
20090082844 | Zacharias et al. | Mar 2009 | A1 |
20090082847 | Zacharias et al. | Mar 2009 | A1 |
20090088832 | Chew et al. | Apr 2009 | A1 |
20090112309 | Jaramillo et al. | Apr 2009 | A1 |
20090118744 | Wells et al. | May 2009 | A1 |
20090118824 | Samkov | May 2009 | A1 |
20090118826 | Khaghani | May 2009 | A1 |
20090125096 | Chu et al. | May 2009 | A1 |
20090132035 | Roth et al. | May 2009 | A1 |
20090138079 | Tuval et al. | May 2009 | A1 |
20090149946 | Dixon | Jun 2009 | A1 |
20090157175 | Benichou | Jun 2009 | A1 |
20090163934 | Raschdorf, Jr. et al. | Jun 2009 | A1 |
20090171438 | Chuter et al. | Jul 2009 | A1 |
20090171456 | Kveen et al. | Jul 2009 | A1 |
20090177262 | Oberti et al. | Jul 2009 | A1 |
20090182407 | Leanna et al. | Jul 2009 | A1 |
20090182413 | Burkart et al. | Jul 2009 | A1 |
20090188964 | Orlov | Jul 2009 | A1 |
20090192601 | Rafiee et al. | Jul 2009 | A1 |
20090216314 | Quadri | Aug 2009 | A1 |
20090216317 | Cromack et al. | Aug 2009 | A1 |
20090222076 | Figulla et al. | Sep 2009 | A1 |
20090227992 | Nir et al. | Sep 2009 | A1 |
20090234443 | Ottma et al. | Sep 2009 | A1 |
20090248132 | Bloom et al. | Oct 2009 | A1 |
20090248133 | Bloom et al. | Oct 2009 | A1 |
20090258958 | Ford | Oct 2009 | A1 |
20090264989 | Bonhoeffer et al. | Oct 2009 | A1 |
20090264997 | Salahieh et al. | Oct 2009 | A1 |
20090270972 | Lane | Oct 2009 | A1 |
20090276040 | Rowe et al. | Nov 2009 | A1 |
20090281618 | Hill et al. | Nov 2009 | A1 |
20090281619 | Le et al. | Nov 2009 | A1 |
20090287296 | Manasse | Nov 2009 | A1 |
20090287299 | Tabor et al. | Nov 2009 | A1 |
20090292350 | Eberhardt et al. | Nov 2009 | A1 |
20090306768 | Quadri | Dec 2009 | A1 |
20090318871 | Zarbatany et al. | Dec 2009 | A1 |
20100004740 | Seguin et al. | Jan 2010 | A1 |
20100036479 | Hill et al. | Feb 2010 | A1 |
20100049306 | House et al. | Feb 2010 | A1 |
20100082089 | Quadri et al. | Apr 2010 | A1 |
20100082094 | Quadri et al. | Apr 2010 | A1 |
20100094411 | Tuval et al. | Apr 2010 | A1 |
20100114299 | Ben Muvhar et al. | May 2010 | A1 |
20100114305 | Kang et al. | May 2010 | A1 |
20100121461 | Sobrino-Serrano et al. | May 2010 | A1 |
20100161027 | Orr | Jun 2010 | A1 |
20100179633 | Solem et al. | Jul 2010 | A1 |
20100179647 | Carpenter et al. | Jul 2010 | A1 |
20100191326 | Alkhatib | Jul 2010 | A1 |
20100217382 | Chau et al. | Aug 2010 | A1 |
20100249894 | Oba et al. | Sep 2010 | A1 |
20100249908 | Chau et al. | Sep 2010 | A1 |
20100256723 | Murray | Oct 2010 | A1 |
20100262157 | Silver et al. | Oct 2010 | A1 |
20100274345 | Rust | Oct 2010 | A1 |
20100280606 | Naor | Nov 2010 | A1 |
20100286768 | Alkhatib | Nov 2010 | A1 |
20100292780 | Straubinger | Nov 2010 | A1 |
20100298931 | Quadri | Nov 2010 | A1 |
20100305685 | Millwee et al. | Dec 2010 | A1 |
20100312333 | Navia et al. | Dec 2010 | A1 |
20110004296 | Lutter et al. | Jan 2011 | A1 |
20110015731 | Carpentier et al. | Jan 2011 | A1 |
20110022157 | Essinger et al. | Jan 2011 | A1 |
20110022165 | Oba et al. | Jan 2011 | A1 |
20110029067 | McGuckin, Jr. et al. | Feb 2011 | A1 |
20110114230 | Syed et al. | May 2011 | A1 |
20110137397 | Chau et al. | Jun 2011 | A1 |
20110166644 | Keeble et al. | Jul 2011 | A1 |
20110178597 | Navia et al. | Jul 2011 | A9 |
20110208297 | Tuval et al. | Aug 2011 | A1 |
20110208298 | Tuval et al. | Aug 2011 | A1 |
20110218619 | Benichou et al. | Sep 2011 | A1 |
20110224678 | Gabbay | Sep 2011 | A1 |
20110224785 | Hacohen | Sep 2011 | A1 |
20110264196 | Savage et al. | Oct 2011 | A1 |
20110282438 | Drews et al. | Nov 2011 | A1 |
20110301704 | Alfieri et al. | Dec 2011 | A1 |
20110313515 | Quadri et al. | Dec 2011 | A1 |
20110319981 | Hill et al. | Dec 2011 | A1 |
20110319989 | Lane et al. | Dec 2011 | A1 |
20120012487 | Tian et al. | Jan 2012 | A1 |
20120016342 | Brecker | Jan 2012 | A1 |
20120016411 | Tuval | Jan 2012 | A1 |
20120022605 | Jahns et al. | Jan 2012 | A1 |
20120022639 | Hacohen et al. | Jan 2012 | A1 |
20120022642 | Haug et al. | Jan 2012 | A1 |
20120029627 | Salahieh et al. | Feb 2012 | A1 |
20120035703 | Lutter et al. | Feb 2012 | A1 |
20120035713 | Lutter et al. | Feb 2012 | A1 |
20120041550 | Salahieh et al. | Feb 2012 | A1 |
20120041551 | Spenser et al. | Feb 2012 | A1 |
20120059452 | Boucher et al. | Mar 2012 | A1 |
20120059454 | Millwee et al. | Mar 2012 | A1 |
20120078353 | Quadri et al. | Mar 2012 | A1 |
20120078360 | Rafiee | Mar 2012 | A1 |
20120101571 | Thambar et al. | Apr 2012 | A1 |
20120101572 | Kovalsky et al. | Apr 2012 | A1 |
20120123529 | Levi et al. | May 2012 | A1 |
20120179051 | Pfeiffer et al. | Jul 2012 | A1 |
20120179239 | Quadri | Jul 2012 | A1 |
20120179243 | Yang et al. | Jul 2012 | A1 |
20120185033 | Ryan | Jul 2012 | A1 |
20120215303 | Quadri et al. | Aug 2012 | A1 |
20120259405 | Weber et al. | Oct 2012 | A1 |
20120259409 | Nguyen et al. | Oct 2012 | A1 |
20120271398 | Essinger et al. | Oct 2012 | A1 |
20120283820 | Tseng et al. | Nov 2012 | A1 |
20120283824 | Lutter et al. | Nov 2012 | A1 |
20120290062 | McNamara et al. | Nov 2012 | A1 |
20120296418 | Bonyuet et al. | Nov 2012 | A1 |
20120303116 | Gorman, III et al. | Nov 2012 | A1 |
20120310328 | Olson et al. | Dec 2012 | A1 |
20120323316 | Chau et al. | Dec 2012 | A1 |
20120330409 | Haug et al. | Dec 2012 | A1 |
20130006294 | Kashkarov et al. | Jan 2013 | A1 |
20130018458 | Yohanan et al. | Jan 2013 | A1 |
20130030418 | Taft et al. | Jan 2013 | A1 |
20130030523 | Padala et al. | Jan 2013 | A1 |
20130046378 | Millwee et al. | Feb 2013 | A1 |
20130053949 | Pintor et al. | Feb 2013 | A1 |
20130053950 | Rowe et al. | Feb 2013 | A1 |
20130095264 | Sowinski et al. | Apr 2013 | A1 |
20130096671 | Iobbi | Apr 2013 | A1 |
20130110226 | Gurskis | May 2013 | A1 |
20130110227 | Quadri et al. | May 2013 | A1 |
20130110230 | Solem | May 2013 | A1 |
20130116777 | Pintor et al. | May 2013 | A1 |
20130131788 | Quadri et al. | May 2013 | A1 |
20130131793 | Quadri et al. | May 2013 | A1 |
20130138203 | Quadri | May 2013 | A1 |
20130138207 | Quadri et al. | May 2013 | A1 |
20130144375 | Giasolli et al. | Jun 2013 | A1 |
20130144378 | Quadri et al. | Jun 2013 | A1 |
20130144380 | Quadri et al. | Jun 2013 | A1 |
20130144381 | Quadri et al. | Jun 2013 | A1 |
20130150956 | Yohanan et al. | Jun 2013 | A1 |
20130166024 | Drews et al. | Jun 2013 | A1 |
20130172983 | Clerc et al. | Jul 2013 | A1 |
20130184813 | Quadri et al. | Jul 2013 | A1 |
20130184814 | Huynh et al. | Jul 2013 | A1 |
20130211508 | Lane et al. | Aug 2013 | A1 |
20130236889 | Kishimoto et al. | Sep 2013 | A1 |
20130238087 | Taylor | Sep 2013 | A1 |
20130245615 | Koltz | Sep 2013 | A1 |
20130245736 | Alexander et al. | Sep 2013 | A1 |
20130253635 | Straubinger et al. | Sep 2013 | A1 |
20130253637 | Wang et al. | Sep 2013 | A1 |
20130253639 | Alkhatib | Sep 2013 | A1 |
20130253641 | Lattouf | Sep 2013 | A1 |
20130253642 | Brecker | Sep 2013 | A1 |
20130261737 | Costello | Oct 2013 | A1 |
20130261738 | Clague et al. | Oct 2013 | A1 |
20130268069 | Zakai et al. | Oct 2013 | A1 |
20130289695 | Tian et al. | Oct 2013 | A1 |
20130304200 | McLean et al. | Nov 2013 | A1 |
20130310928 | Morriss et al. | Nov 2013 | A1 |
20130325098 | Desai et al. | Dec 2013 | A1 |
20130325121 | Whatley et al. | Dec 2013 | A1 |
20130331714 | Manstrom et al. | Dec 2013 | A1 |
20130338764 | Thornton et al. | Dec 2013 | A1 |
20130338765 | Braido et al. | Dec 2013 | A1 |
20130345786 | Behan | Dec 2013 | A1 |
20130345803 | Bergheim, III | Dec 2013 | A1 |
20140018912 | Delaloye et al. | Jan 2014 | A1 |
20140031930 | Keidar et al. | Jan 2014 | A1 |
20140039612 | Dolan | Feb 2014 | A1 |
20140039614 | Delaloye et al. | Feb 2014 | A1 |
20140044689 | Liu et al. | Feb 2014 | A1 |
20140046219 | Sauter et al. | Feb 2014 | A1 |
20140046427 | Michalak | Feb 2014 | A1 |
20140052242 | Revuelta et al. | Feb 2014 | A1 |
20140081393 | Hasenkam et al. | Mar 2014 | A1 |
20140086934 | Shams | Mar 2014 | A1 |
20140088685 | Yevzlin et al. | Mar 2014 | A1 |
20140088694 | Rowe et al. | Mar 2014 | A1 |
20140100420 | Mortier et al. | Apr 2014 | A1 |
20140100651 | Kheradvar et al. | Apr 2014 | A1 |
20140100653 | Savage et al. | Apr 2014 | A1 |
20140107761 | Gale et al. | Apr 2014 | A1 |
20140142694 | Tabor et al. | May 2014 | A1 |
20140155990 | Nyuli | Jun 2014 | A1 |
20140163668 | Rafiee | Jun 2014 | A1 |
20140172085 | Quadri et al. | Jun 2014 | A1 |
20140172086 | Quadri et al. | Jun 2014 | A1 |
20140186417 | Trollsas et al. | Jul 2014 | A1 |
20140194978 | Seguin et al. | Jul 2014 | A1 |
20140194981 | Menk et al. | Jul 2014 | A1 |
20140194982 | Kovalsky et al. | Jul 2014 | A1 |
20140194983 | Kovalsky et al. | Jul 2014 | A1 |
20140214153 | Ottma et al. | Jul 2014 | A1 |
20140214154 | Nguyen et al. | Jul 2014 | A1 |
20140214155 | Kelley | Jul 2014 | A1 |
20140214160 | Naor | Jul 2014 | A1 |
20140215791 | Soundararajan et al. | Aug 2014 | A1 |
20140221823 | Keogh et al. | Aug 2014 | A1 |
20140222136 | Geist et al. | Aug 2014 | A1 |
20140222139 | Nguyen et al. | Aug 2014 | A1 |
20140222142 | Kovalsky et al. | Aug 2014 | A1 |
20140230515 | Tuval et al. | Aug 2014 | A1 |
20140236288 | Lambrecht et al. | Aug 2014 | A1 |
20140243966 | Garde et al. | Aug 2014 | A1 |
20140249622 | Carmi et al. | Sep 2014 | A1 |
20140256035 | Strasly et al. | Sep 2014 | A1 |
20140257467 | Lane et al. | Sep 2014 | A1 |
20140257475 | Gross et al. | Sep 2014 | A1 |
20140257476 | Montorfano et al. | Sep 2014 | A1 |
20140277390 | Ratz et al. | Sep 2014 | A1 |
20140277402 | Essinger et al. | Sep 2014 | A1 |
20140277422 | Ratz et al. | Sep 2014 | A1 |
20140277423 | Alkhatib et al. | Sep 2014 | A1 |
20140277427 | Ratz et al. | Sep 2014 | A1 |
20140296973 | Bergheim et al. | Oct 2014 | A1 |
20140296975 | Tegels et al. | Oct 2014 | A1 |
20140303719 | Cox et al. | Oct 2014 | A1 |
20140309728 | Dehdashtian et al. | Oct 2014 | A1 |
20140309731 | Quadri et al. | Oct 2014 | A1 |
20140309732 | Solem | Oct 2014 | A1 |
20140324160 | Benichou et al. | Oct 2014 | A1 |
20140324164 | Gross et al. | Oct 2014 | A1 |
20140336754 | Gurskis et al. | Nov 2014 | A1 |
20140350565 | Yacoby et al. | Nov 2014 | A1 |
20140350666 | Righini | Nov 2014 | A1 |
20140356519 | Hossainy et al. | Dec 2014 | A1 |
20140358223 | Rafiee et al. | Dec 2014 | A1 |
20140364404 | Cleek et al. | Dec 2014 | A1 |
20140364944 | Lutter et al. | Dec 2014 | A1 |
20140370071 | Chen et al. | Dec 2014 | A1 |
20140371845 | Tuval et al. | Dec 2014 | A1 |
20140371847 | Madrid et al. | Dec 2014 | A1 |
20140371848 | Murray, III et al. | Dec 2014 | A1 |
20140379067 | Nguyen et al. | Dec 2014 | A1 |
20140379068 | Thielen et al. | Dec 2014 | A1 |
20140379077 | Tuval et al. | Dec 2014 | A1 |
20150012085 | Salahieh et al. | Jan 2015 | A1 |
20150018938 | Von Segesser et al. | Jan 2015 | A1 |
20150018944 | O'Connell et al. | Jan 2015 | A1 |
20150032153 | Quadri et al. | Jan 2015 | A1 |
20150045881 | Lim | Feb 2015 | A1 |
20150066140 | Quadri et al. | Mar 2015 | A1 |
20150081009 | Quadri et al. | Mar 2015 | A1 |
20150086603 | Hossainy et al. | Mar 2015 | A1 |
20150088252 | Jenson et al. | Mar 2015 | A1 |
20150105856 | Rowe et al. | Apr 2015 | A1 |
20150142103 | Vidlund | May 2015 | A1 |
20150148731 | McNamara et al. | May 2015 | A1 |
20150157458 | Thambar et al. | Jun 2015 | A1 |
20150209137 | Quadri et al. | Jul 2015 | A1 |
20150209141 | Braido et al. | Jul 2015 | A1 |
20150216653 | Freudenthal | Aug 2015 | A1 |
20150216655 | Lane et al. | Aug 2015 | A1 |
20150238315 | Rabito et al. | Aug 2015 | A1 |
20150305864 | Quadri et al. | Oct 2015 | A1 |
20150328000 | Ratz et al. | Nov 2015 | A1 |
20150342736 | Rabito et al. | Dec 2015 | A1 |
20160038281 | Delaloye et al. | Feb 2016 | A1 |
20160228251 | Nyuli et al. | Aug 2016 | A1 |
Number | Date | Country |
---|---|---|
2263006 | Aug 1999 | CA |
2304325 | Oct 2000 | CA |
102196784 | Sep 2011 | CN |
102256568 | Nov 2011 | CN |
3128704 | Feb 1983 | DE |
102006052564 | Dec 2007 | DE |
0657147 | Jun 1995 | EP |
1255510 | Apr 2007 | EP |
1472996 | Sep 2009 | EP |
1264471 | Feb 1972 | GB |
1315844 | May 1973 | GB |
2245495 | Jan 1992 | GB |
2398245 | Aug 2004 | GB |
2002540889 | Dec 2002 | JP |
2008541865 | Nov 2008 | JP |
WO-9749355 | Dec 1997 | WO |
WO-9819633 | May 1998 | WO |
WO-0053104 | Sep 2000 | WO |
WO-0061034 | Oct 2000 | WO |
WO-0135861 | May 2001 | WO |
WO-0135870 | May 2001 | WO |
WO-0172239 | Oct 2001 | WO |
WO-0211646 | Feb 2002 | WO |
WO-0236048 | May 2002 | WO |
WO-03028522 | Apr 2003 | WO |
WO-03092554 | Nov 2003 | WO |
WO-2004014257 | Feb 2004 | WO |
WO-2004014474 | Feb 2004 | WO |
WO-2004058097 | Jul 2004 | WO |
WO-2005011534 | Feb 2005 | WO |
WO-2005041810 | May 2005 | WO |
WO-2005087140 | Sep 2005 | WO |
WO-2006070372 | Jul 2006 | WO |
WO-2006085304 | Aug 2006 | WO |
WO-2006089236 | Aug 2006 | WO |
WO-2006097931 | Sep 2006 | WO |
WO-2006127765 | Nov 2006 | WO |
WO-2007025028 | Mar 2007 | WO |
WO-2007034488 | Mar 2007 | WO |
WO-2007058857 | May 2007 | WO |
WO-2007122459 | Nov 2007 | WO |
WO-2007123658 | Nov 2007 | WO |
WO-2007134290 | Nov 2007 | WO |
WO-2008005535 | Jan 2008 | WO |
WO-2008013915 | Jan 2008 | WO |
WO-2008070797 | Jun 2008 | WO |
WO-2008091515 | Jul 2008 | WO |
WO-2008103722 | Aug 2008 | WO |
WO-2008150529 | Dec 2008 | WO |
WO-2009026563 | Feb 2009 | WO |
WO-2009033469 | Mar 2009 | WO |
WO-2009045331 | Apr 2009 | WO |
WO-2009052188 | Apr 2009 | WO |
WO-2009053497 | Apr 2009 | WO |
WO-2009091509 | Jul 2009 | WO |
WO-2009094500 | Jul 2009 | WO |
WO-2009134701 | Nov 2009 | WO |
WO-2009137359 | Nov 2009 | WO |
WO-2009149462 | Dec 2009 | WO |
WO-2009155561 | Dec 2009 | WO |
WO-2010004546 | Jan 2010 | WO |
WO-2010008549 | Jan 2010 | WO |
WO-2010037141 | Apr 2010 | WO |
WO-2010040009 | Apr 2010 | WO |
WO-2010057262 | May 2010 | WO |
WO-2010098857 | Sep 2010 | WO |
WO-2010130789 | Nov 2010 | WO |
WO-2010138853 | Dec 2010 | WO |
WO-2011025945 | Mar 2011 | WO |
WO-2011109813 | Sep 2011 | WO |
WO-2011137531 | Nov 2011 | WO |
WO-2012035279 | Mar 2012 | WO |
WO-2012162228 | Nov 2012 | WO |
WO-2012177942 | Dec 2012 | WO |
Entry |
---|
US 8,062,357 B2, 11/2011, Salahieh et al. (withdrawn) |
US 8,221,315 B2, 07/2012, Lambrecht et al. (withdrawn) |
Notice of Allowance dated Nov. 7, 2017 for U.S. Appl. No. 15/134,164. |
Office Action dated Jan. 11, 2017 for U.S. Appl. No. 15/134,164. |
Office Action dated Jul. 21, 2017 for U.S. Appl. No. 15/134,164. |
50 Early-to Late-Stage Medical Device Companies Seeking Investment and Partnering Opportunities to Present in 3 Weeks at Investment in Innovation (In3) Medical Device Summit. Businesswire.com. Dated May 27, 2008. 3 pages. |
Al-Attar. Next generation surgical aortic biological prostheses: sutureless valves. European Society of Cardiology. Dec. 21, 2011; 10(14):1-3. |
Banai, et al. Tiara: a novel catheter-based mitral valve bioprosthesis: initial experiments and short-term pre-clinical results. J Am Coll Cardiol. Oct. 9, 2012;60(15):1430-1. doi: 10.1016/j.jacc.2012.05.047. Epub Sep. 12, 2012. |
Bavaria. CardiAQ Valve Technologies (CVT) discloses successful results of acute in vivo study of its novel transcatheter mitral valve implantation (TMVI) system. Enhanced Online News. Sep. 28, 2009. Accessed: Mar. 8, 2012. http://eon.businesswire.com/news/eon/20090928005120/en/CardiAQ-Valve-Technologies/Heart/heart-failure. |
Bavaria. CardiAQ Valve Technologies. TCT Company Overview. Transcatheter Cardiovascular Therapeutics Conference. San Francisco, CA. Sep. 21-25, 2009. |
Berreklouw, et al. Sutureless mitral valve replacement with bioprostheses and Nitinol attachment rings: feasibility in acute pig experiments. J Thorac Cardiovasc Surg. Aug. 2011;142(2):390-5.e1. doi: 10.1016/j.jtcvs.2010.12.018. Epub Feb. 4, 2011. |
Boudjemline, et al. Steps toward the percutaneous replacement of atrioventricular valves an experimental study. J Am Coll Cardiol. Jul. 19, 2005;46(2):360-5. |
Brinkman, et al. Transcatheter cardiac valve interventions. Surg Clin North Am. Aug. 2009;89(4):951-66, x. doi: 10.1016/j.suc.2009.06.004. |
CardiAQ's Complaint and Jury Demand; U.S. District Court—District of Massachusetts; Case No. 1:14-cv-12405-ADB; CardiAQ Valve, Technologies Inc. v. Neovasc Inc. and Neovasc Tiara Inc.; filed Jun. 6, 2014. 22 pages. |
CardiAQ's First Amended Complaint and Jury Demand; U.S. District Court—District of Massachusetts; Case No. 1:14-cv-12405-ADB; CardiAQ Valve, Technologies Inc. v. Neovasc Inc. and Neovasc Tiara Inc.; filed Aug. 12, 2014. 21 pages. |
CardiAQ's Objection in Patent Vindication Action in regard to EP 2 566 416; Administrative Court of Munich; CardiAQ Valve Technologies, Inc., v. Neovasc Tiara Inc.; filed on Jun. 25, 2014. 22 pages. |
CardiAQ's Second Amended Complaint and Jury Demand; U.S. District Court—District of Massachusetts; Case No. 1:14-cv-12405-ADB; CardiAQ Valve, Technologies Inc. v. Neovasc Inc. and Neovasc Tiara Inc.; filed Jan. 15, 2015. 25 pages. |
CardiAQ Valve Technologies (CVT) Elects Michael Mack, MD, to its Scientific Advisory Board. “CVT's Transcatheter Mitral Valve Implanation (TMVI) platform might be the ‘next big thing’ in the cardiac cath lab.” BusinessWire. Dated Jun. 2, 2009. 4 pages. |
CardiAQ Valve Technologies (“CVT”) to disclose data during ‘EuroPCR 2010’ about the world's first successful in vivo transcatheter delivery of a mitral heart valve implant. Irvine, California, Businesswire.com. Dated May 20, 2010. 2 pages. |
CardiAQ Valve Technologies. Percutaneous mitral valve replacement. Start-Up. Jun. 2009; 14(6):48-49. |
CardiAQ Valve Technologies to pursue first-in-man studies of its transcatheter mitral valve system. Cardiac Interventions Today. Jan. 12, 2010. |
Carpentier-Edwards. Why compromise in the mitral position? Edwards Lifesciences. 2004. |
Chiam, et al. Percutaneous transcatheter aortic valve implantation: assessing results, judging outcomes, and planning trials: the interventionalist perspective. JACC Cardiovasc Interv. Aug. 2008;1(4):341-50. doi: 10.1016/j.jcin.2008.03.018. |
Company Fact Sheet—CardiAQ Valve Technologies. 2009. 1 page. |
Company Overview—CardiAQ Valve Technologies. Dated Jun. 25, 2009 at TVT. 17 pages. |
Condado, et al. Percutaneous treatment of heart valves. Rev Esp Cardiol. Dec. 2006;59(12):1225-31. |
CoreValve USA. An advanced TAVR design. Medtronic.com. Accessed Jan. 27, 2015. |
Court's Memorandum & Order; U.S. District Court—District of Massachusetts; Case No. 1:14-cv-12405-ADB; CardiAQ Valve, Technologies Inc. v. Neovasc Inc. and Neovasc Tiara Inc.; filed Nov. 6, 2014. 14 pages. |
De Backer, et al. Percutaneous transcatheter mitral valve replacement: an overview of devices in preclinical and early clinical evaluation. Circ Cardiovasc Interv. Jun. 2014;7(3):400-9. doi: 10.1161/CIRCINTERVENTIONS.114.001607. |
Defendants Neovasc Inc.'s and Neovasc Tiara Inc.'s Answer to Plaintiff's First Amended Complaint; U.S. District Court—District of Massachusetts; Case No. 1:14-cv-12405-ADB; CardiAQ Valve, Technologies Inc. v. Neovasc Inc. and Neovasc Tiara Inc.; filed Nov. 20, 2014. 20 pages. |
Defendants Neovasc Inc.'s and Neovasc Tiara Inc.'s Answer to Plaintiff's Second Amended Complaint; U.S. District Court—District of Massachusetts; Case No. 1:14-cv-12405-ADB; CardiAQ Valve, Technologies Inc. v. Neovasc Inc. and Neovasc Tiara Inc.; filed Jan. 29, 2015. 22 pages. |
Edwards Lifesciences 2005 annual report. Accessed Jan. 27, 2015. |
European Extended Search Report dated Jan. 30, 2014 for EP Application No. EP 11798780. |
European Extended Search Report dated Feb. 28, 2013 for EP Application No. EP 06827638. |
“European search report and opinion dated Sep. 14, 2015 for EP Application No. 13796278.3.” |
Exhibits accompanying CardiAQ's Objection in Patent Vindication Action in regard to EP 2 566 416; filed on Jun. 25, 2014. 306 pages. |
Exhibits accompanying Neovasc's Statement of Defense in Patent Vindication Action in regard to EP 2 566 416; filed on Dec. 9, 2014. 67 pages. |
Fanning, et al. Transcatheter aortic valve implantation (TAVI): valve design and evolution. Int J Cardiol. Oct. 3, 2013;168(3):1822-31. doi: 10.1016/j.ijcard.2013.07.117. Epub Aug. 20, 2013. |
Feldman, et al. Prospects for percutaneous valve therapies. Circulation. Dec. 11, 2007;116(24):2866-77. |
Fitzgerald. Tomorrow's technology: percutaneous mitral valve replacement, chordal shortening and beyond. Transcatheter Valve Therapies (TVT) Conference. Seattle, WA. Jun. 7, 2010. |
Gillespie, et al. Sutureless mitral valve replacement: initial steps toward a percutaneous procedure. Ann Thorac Surg. Aug. 2013;96(2):670-4. doi: 10.1016/j.athoracsur.2013.02.065. |
Grube, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. Jul. 3, 2007;50(1):69-76. Epub Jun. 6, 2007. |
Grube, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation. Oct. 10, 2006;114(15):1616-24. Epub Oct. 2, 2006. |
Harmon, et al. Effect of acute myocardial infarction on the angle between the mitral and aortic valve plane. Am J Cardiol. Aug. 1, 1999;84(3):342-4, A8. |
Herrman. Trancatheter mitral valve implantation. Cardiac Interventions Today. Aug./Sep. 2009; 81-85. |
Horvath, et al. Transapical aortic valve replacement under real-time magnetic resonance imaging guidance: experimental results with balloon-expandable and self-expanding stents. Eur J Cardiothorac Surg. Jun. 2011;39(6):822-8. doi: 10.1016/j.ejcts.2010.09.030. Epub Oct. 22, 2010. |
International Search Report and Written Opinion dated Feb. 29, 2012 for PCT/US2011/041306. |
International Search Report and Written Opinion dated Mar. 26, 2008 for PCT/US2007/016855. |
International Search Report and Written Opinion dated Jun. 25, 2008 for PCT/US2006/043526. |
International search report and written opinion dated Sep. 4, 2013 for PCT/CA2013/000530. |
International Search Report and Written Opinion dated Dec. 11, 2009 for PCT/US2009/058893. |
International Search Report and Written Opinion dated Dec. 18, 2009 for PCT/US2009/059299. |
International Search Report and Written Opinion dated Dec. 22, 2010 for PCT/US2010/031313. |
Ionasec, et al. Personalized modeling and assessment of the aortic-mitral coupling from 4D TEE and CT. Med Image Comput Comput Assist Interv. 2009;12(Pt 2):767-75. |
Karimi, et al. Percutaneous Valve Therapies. SIS 2007 Year book. Chapter 11. 11 pages. |
Kronemyer. CardiAQ Valve Technologies: Percutaneous Mitral Valve Replacement. Start Up—Windhover Review of Emerging Medical Ventures, vol. 14, No. 6, Jun. 2009, pp. 48-49. |
Kumar, et al. Design considerations and quantitative assessment for the development of percutaneous mitral valve stent. Med Eng Phys. Jul. 2014;36(7):882-8. doi: 10.1016/j.medengphy.2014.03.010. Epub Apr. 16, 2014. |
Lansac, et al. Dynamic balance of the aortomitral junction. J Thorac Cardiovasc Surg. May 2002;123(5):911-8. |
Lauten, et al. Experimental evaluation of the JenaClip transcatheter aortic valve. Catheter Cardiovasc Interv. Sep. 1, 2009;74(3):514-9. doi: 10.1002/ccd.22093. |
Lauten; et al., “Experimental evaluation of the JenaClip transcatheter aortic valve.”, Catheter Cardiovasc Interv., Sep. 1, 2009, 74(3), 514-9. |
Leon, et al. Transcatheter aortic valve replacement in patients with critical aortic stenosis: rationale, device descriptions, early clinical experiences, and perspectives. Semin Thorac Cardiovasc Surg. 2006 Summer;18(2):165-74. |
Lozonschi, et al. Transapical mitral valved stent implantation. Ann Thorac Surg. Sep. 2008;86(3):745-8. doi: 10.1016/j.athoracsur.2008.05.039. |
Lutter, et al. Off-pump transapical mitral valve replacement. Eur J Cardiothorac Surg. Jul. 2009;36(1):124-8; discussion 128. doi: 10.1016/j.ejcts.2009.02.037. Epub Apr. 25, 2009. |
Lutter, et al. Transapical mitral valve implantation: the Lutter valve. Heart Lung Vessel. 2013;5(4):201-6. |
Lutter, G et al.: “Transcatheter Mitral Valve Replacement—Early Animal Results,” Universitatsklinikum, Schleswig-Holstein. Aug. 28, 2012. |
Ma, et al. Double-crowned valved stents for off-pump mitral valve replacement. Eur J Cardiothorac Surg. Aug. 2005;28(2):194-8; discussion 198-9. |
Mack. Advantages and limitations of surgical mitral valve replacement; lessons for the transcatheter approach. Jun. 7, 2010. Texas Cardiovascular Innovative Ventures (TCIV) Conference. Dallas, TX. Dec. 8, 2010. |
Mack, Michael, M.D., “Antegrade Transcatheter Mitral valve Implantation: A Short-term Experience in Swine Model.” Applicant believes this may have been presented on May of 2011 at TVT. 10 pages. |
Maisano, et al. Mitral transcatheter technologies. Rambam Maimonides Med J. Jul. 25, 2013;4(3):e0015. doi: 10.5041/RMMJ.10115. Print Jul. 2013. |
Masson, et al. Percutaneous treatment of mitral regurgitation. Circ Cardiovasc Interv. Apr. 2009;2(2):140-6. doi: 10.1161/CIRCINTERVENTIONS.108.837781. |
Medical Devices Today. CardiAQ Valve Technologies. Start-Up—Jul. 17, 2009. Accessed: Mar. 8, 2012. http:/www.medicaldevicestoday.com/2009/07/medical-device-start-up-cardiaq-valve-technologies-percutaneous-mitral-valve-replacement.html. |
Navia, et al. Sutureless implantation a expandable mitral stent-valve prosthesis in acute animal model. TCT728. JACC. Nov. 8, 2011. vol. 58, No. 20 Suppl B. B194. |
Neovasc corporate presentation, Oct. 2009. 21 pages. Available at http://www.neovasc.com/investors/documents/Neovasc-Corporate-Presentation-October-2009.pdf. |
Neovasc Ostial Products Overview. 1 page.https://web.archive.org/web/20090930050359/https://www.neovasc.com/vascular-products/ostialproducts/default.php (Neovasc website archived as of Sep. 30, 2008). |
Neovasc's Statement of Defense in Patent Vindication Action in regard to EP 2 566 416; Administrative Court of Munich; CardiAQ Valve Technologies, Inc., v. Neovasc Tiara Inc.; filed on Dec. 9, 2014. 39 pages. |
Neovasc Surgical Products: An Operating Division of Neovasc Inc. Dated Apr. 2009. 17 pages. |
Nkomo, et al. Burden of valvular heart diseases: a population-based study. Lancet. Sep. 16, 2006;368(9540):1005-11. |
Notice of allowance dated Mar. 15, 2016 for U.S. Appl. No. 13/904,827. |
Office action dated Sep. 1, 2015 for U.S. Appl. No. 13/904,827. |
Ormiston, et al. Size and motion of the mitral valve annulus in man. I. A two-dimensional echocardiographic method and findings in normal subjects. Circulation. Jul. 1981;64(1):113-20. |
Orton. Mitralseal: hybrid trancatheter mitral valve replacement. Colorado State University. 2011; 311-312. https://www.acvs.org/files/proceedings/2011/data/papers/102.pdf. |
Ostrovsky, Gene, “A Trial of Zenith Fenestrated AAA Endovascular Graft Goes On,” medGadget, Aug. 1, 2008, 9 pages. Available at: http://www.medgadget.com/2008/08/a_trial_of_zenith_fenestrated_aaa_endovascular_graft_goes_on.html. |
Ostrovsky. Transcatheter mitral valve implantation technology from CardiAQ. Posted Jan. 15, 2010. Accessed Jun. 27, 2012 from http://medgadget.com/2010/01/transcatheter_mitral_valve_implantation_technology_from_cardiaq.html. |
Otto. Clinical practice. Evaluation and management of chronic mitral regurgitation. N Engl J Med. Sep. 6, 2001;345(10):740-6. |
Piazza, et al. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv. Aug. 2008;1(1):74-81. doi: 10.1161/CIRCINTERVENTIONS.108.780858. |
Pluth, et al. Aortic and mitral valve replacement with cloth-covered Braunwald-Cutter prosthesis. A three-year follow-up. Ann Thorac Surg. Sep. 1975;20(3):239-48. |
Preston-Maher, et al. A Technical Review of Minimally Invasive Mitral Valve Replacements. Cardiovasc Eng Technol. 2015;6(2):174-184. Epub Nov. 25, 2014. |
Quadri, Arshad M.D., “Transcatheter Mitral Valve Implantation (TMVI) (An Acute In Vivo Study),” Applicant believes this may have been presented on Sep. 22, 2010 at TCT. 19 pages. |
Quadri, et al. CVT is developing a non-surgical apporach to replacing mitral valves that may be the alternative to open-chest surgery. CardiAQ Valve Technologies. May 8, 2009. |
Ratz. CardiAQ Valve Technologies. Innovations in heartvalve therapy. IN3 San Francisco. Jun. 18, 2008. PowerPoint presentation in 19 slides. |
Ratz, et al. “Any experiences making an expandable stent frame?” Arch-Pub.com, Architecture Forums: Modeling, Multiple forum postings from Feb. 3, 2009 to Feb. 4, 2009, http://www.arch-pub.com/Any-experiences-making-an-expandable-stent-frame_10601513.html. 5 pages. |
Ratz, J. Brent et al., “Fabric, Skin, Cloth expansion . . . best approach?,” AREA byAutodesk, 3ds Max: Modeling, Forum postings from Feb. 18, 2009 to Feb. 19, 2009, http://forums.autodesk.com/t5/modeling/fabric-skin-cloth-expansion-best-approach/td-p/4062607. 3 pages. |
Ratz, J. Brent et al., “Isolating Interpolation,” Arch-Pub.com, Architecture Forums: Animation and Rigging, Forum postings from Feb. 9, 2009 to Feb. 10, 2009, http://www.arch-pub.com/Isolating-Interpolation_10593153.html. 2 pages. |
Ratz, J. Brent, “In3 Company Overview,” Jun. 24, 2009. 15 pages. |
Ratz, J. Brent, “LSI EMT Spotlight,” May 15, 2009. 21 pages. |
Ribiero, et al. Balloon-expandable prostheses for transcatheter aortic valve replacement. Prog Cardiovasc Dis. May-Jun. 2014;56(6):583-95. doi: 10.1016/j.pcad.2014.02.001. Epub Mar. 1, 2014. |
Ross, Renal Ostial Stent System with Progressi-flex Technology, Evasc Medical Systems. 1 page. Applicant requests the Examiner to consider this reference to be prior art as of Jun. 2009. |
Ruiz. Overview of novel transcatheter valve technologies. Glimpse into the future. New transcatheter mitral valve treatment. Euro PCR. Paris, France. May 27, 2010. |
Seidel, et al. A mitral valve prosthesis and a study of thrombosis on heart valves in dogs. J Surg Res. May 1962;2:168-75. |
Shuto, et al. Percutaneous transvenous Melody valve-in-ring procedure for mitral valve replacement. J Am Coll Cardiol. Dec. 6, 2011;58(24):2475-80. doi: 10.1016/j.jacc.2011.09.021. |
Sondergaard, et al. First-in-human CardiAQ transcatheter mitral valve implantation via transapical approach. TCT-811. JACC. Sep. 13, 2014. vol. 64, No. 11 Suppl B. B237. |
Spencer, et al. Surgical treatment of valvular heart disease. Part V. Prosthetic replacement of the mitral valve. American Heart Journal. Oct. 1968; 76(4):576-580. |
Spillner, et al. New sutureless ‘atrial mitral-valve prosthesis’ for minimally invasive mitral valve therapy. Textile Research Journal. 2010:1-7. |
TAVR. Engager system. Precise Valve positioning. Accessed Jan. 28, 2015. |
The JenaValve—the prosthesis. JenaValve Technology. Accessed Jan. 28, 2015. |
Timek, et al. Aorto-mitral annular dynamics. Ann Thorac Surg. Dec. 2003;76(6):1944-50. |
Tsang, et al. Changes in aortic-mitral coupling with severe aortic stenosis. JACC. Mar. 9, 2010; vol. 55. Issue 1A. |
Update—CardiAQ Valve Technologies. Presented on Jun. 6, 2010 at TVT. 12 pages. |
Van Mieghem, et al. Anatomy of the mitral valvular complex and its implications for transcatheter interventions for mitral regurgitation. J Am Coll Cardiol. Aug. 17, 2010;56(8):617-26. doi: 10.1016/j.jacc.2010.04.030. |
Veronesi, et al. A study of functional anatomy of aortic-mitral valve coupling using 3D matrix transesophageal echocardiography. Circ Cardiovasc Imaging. Jan. 2009;2(1):24-31. doi: 10.1161/CIRCIMAGING.108.785907. Epub Dec. 2, 2008. |
Vu, et al. Novel sutureless mitral valve implantation method involving a bayonet insertion and release mechanism: a proof of concept study in pigs. J Thorac Cardiovasc Surg. Apr. 2012;143(4):985-8. doi: 10.1016/j.jtcvs.2012.01.037. Epub Feb. 11, 2012. |
Walther, et al. Transapical approach for sutureless stent-fixed aortic valve implantation: experimental results. Eur J Cardiothorac Surg. May 2006;29(5):703-8. Epub Apr. 5, 2006. |
Webb, et al. Transcatheter aortic valve implantation: the evolution of prostheses, delivery systems and approaches. Arch Cardiovasc Dis. Mar. 2012;105(3):153-9. doi: 10.1016/j.acvd.2012.02.001. Epub Mar. 16, 2012. |
Yamada, et al. The left ventricular ostium: an anatomic concept relevant to idiopathic ventricular arrhythmias. Circ Arrhythm Electrophysiol. Dec. 2008;1(5):396-404. doi: 10.1161/CIRCEP.108.795948. |
“Chinese Application Serial No. 201610647657.6, Office Action dated Feb. 27, 2019”, with English translation of claims, 12 pgs. |
Number | Date | Country | |
---|---|---|---|
20180168807 A1 | Jun 2018 | US |
Number | Date | Country | |
---|---|---|---|
61653273 | May 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13904827 | May 2013 | US |
Child | 15134164 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15134164 | Apr 2016 | US |
Child | 15890119 | US |